EIDP (CTA-PA) 10-Q 4 May 23 2023 Q1 Quarterly report Financial data

DEI Document

DEI Document - $ / shares	3 Months Ended
	Mar. 31, 2023	Apr. 27, 2023	Dec. 31, 2022	Mar. 31, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Amendment Flag	false
Document Transition Report	false
Entity File Number	001-38710
Entity Registrant Name	Corteva, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-4979096
Entity Address, Address Line One	9330 Zionsville Road,
Entity Address, City or Town	Indianapolis,
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46268
City Area Code	(833)
Local Phone Number	267-8382
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		710,873,000
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01	$ 0.01
Entity Central Index Key	0001755672
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Small Business	false
Entity Current Reporting Status	Yes
Other Address
Document Information [Line Items]
Entity Address, Address Line One	974 Centre Road,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19805
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	CTVA
Security Exchange Name	NYSE
EID [Member]
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Amendment Flag	false
Document Transition Report	false
Entity File Number	1-815
Entity Registrant Name	EIDP, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	51-0014090
Entity Address, Address Line One	9330 Zionsville Road,
Entity Address, City or Town	Indianapolis,
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	46268
City Area Code	(833)
Local Phone Number	267-8382
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		200
Common Stock, Par Value	$ 0.30	$ 0.30	$ 0.30	$ 0.30
Entity Central Index Key	0000030554
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Small Business	false
Entity Current Reporting Status	Yes
EID [Member] | Other Address
Document Information [Line Items]
Entity Address, Address Line One	974 Centre Road,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	DE
Entity Address, Postal Zip Code	19805
EID [Member] | $3.50 Series Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	$3.50 Series Preferred Stock
Trading Symbol	CTAPrA
Security Exchange Name	NYSE
EID [Member] | $4.50 Series Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	$4.50 Series Preferred Stock
Trading Symbol	CTAPrB
Security Exchange Name	NYSE

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Net Sales		$ 4,884	$ 4,601
Cost of Goods Sold		2,771	2,724
Research and Development Expense		316	268
Selling, General and Administrative Expenses		726	735
Amortization of Intangibles		160	179
Restructuring and Asset related charges, net		33	5
Other income - net		(71)	17
Interest Expense		31	9
Income from continuing operations before income taxes		776	698
Provision for (benefit from) income taxes on continuing operations		169	121
Income from continuing operations after income taxes		607	577
Income (loss) from discontinued operations after income taxes		(8)	(10)
Net income		599	567
Net income attributable to noncontrolling interests		4	3
Net income attributable to Corteva		$ 595	$ 564
Basic earnings (loss) per share of common stock from continuing operations		$ 0.85	$ 0.79
Basic earnings (loss) per share of common stock from discontinued operations		(0.01)	(0.01)
Basic earnings (loss) per share of common stock		0.84	0.78
Diluted earnings (loss) per share of common stock from continuing operations		0.84	0.79
Diluted earnings (loss) per share of common stock from discontinued operations		(0.01)	(0.01)
Diluted earnings (loss) per share of common stock		$ 0.83	$ 0.78
Segment Reconciling Items [Member]
Restructuring and Asset related charges, net	[1]	$ (33)	$ (5)
EID [Member]
Net Sales		4,884	4,601
Cost of Goods Sold		2,771	2,724
Research and Development Expense		316	268
Selling, General and Administrative Expenses		726	735
Amortization of Intangibles		160	179
Restructuring and Asset related charges, net		33	5
Other income - net		(71)	17
Income from continuing operations before income taxes		763	689
Provision for (benefit from) income taxes on continuing operations		166	119
Income from Continuing Operations After Taxes		597	570
Income (loss) from discontinued operations after income taxes		(8)	(10)
Net income		589	560
Net income attributable to noncontrolling interests		1	1
Net income attributable to Corteva		588	559
EID [Member] | Segment Reconciling Items [Member]
Interest Expense		$ 44	$ 18
[1]Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information.

Consolidated Statements of Comp

Consolidated Statements of Comprehensive (Loss) Income - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Net income	$ 599	$ 567
Cumulative Translation Adjustments	134	91
Derivatives Instruments	(67)	(25)
Total other comprehensive income (loss)	67	77
Comprehensive income (loss)	666	644
Comprehensive Income Attributable to Noncontrolling Interest - Net of Tax	4	3
Comprehensive Income (Loss) Attributable to Corteva	662	641
Pension Plan
Adjustments to benefit plans	2	8
Other Benefit Plans
Adjustments to benefit plans	(2)	3
EID [Member]
Net income	589	560
Cumulative Translation Adjustments	134	91
Derivatives Instruments	(67)	(25)
Total other comprehensive income (loss)	67	77
Comprehensive income (loss)	656	637
Comprehensive Income Attributable to Noncontrolling Interest - Net of Tax	1	1
Comprehensive Income (Loss) Attributable to Corteva	655	636
EID [Member] | Pension Plan
Adjustments to benefit plans	2	8
EID [Member] | Other Benefit Plans
Adjustments to benefit plans	$ (2)	$ 3

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2023		Dec. 31, 2022	Mar. 31, 2022
Cash and cash equivalents	$ 1,646		$ 3,191	$ 2,031
Marketable Securities	85		124	290
Accounts and notes receivable - net	8,678		5,701	7,275
Inventories	6,585		6,811	4,986
Other current assets	1,335		968	1,296
Total current assets	18,329		16,795	15,878
Investments in nonconsolidated affiliates	87		102	91
Property, Plant and Equipment	8,633		8,551	8,483
Less: Accumulated Depreciation	4,362		4,297	4,150
Net Property, Plant and Equipment	4,271		4,254	4,333
Goodwill	10,508		9,962	10,109
Other intangible assets	10,137	[1]	9,339	9,865
Deferred Income Taxes	508		479	471
Other assets	1,660		1,687	1,886
Total Assets	45,500		42,618	42,633
Short-term borrowings and finance lease obligations	3,787		24	1,018
Accounts payable	3,957		4,895	3,685
Income Taxes Payable	298		183	180
Deferred Revenue	2,712		3,388	2,435
Accrued and other current liabilities	2,477		2,254	2,335
Total current liabilities	13,231		10,744	9,653
Long-term Debt	1,241		1,283	1,154
Deferred income tax liabilities	1,255		1,119	1,203
Pension and other post employment benefits - noncurrent	2,242		2,255	2,983
Other noncurrent obligations	1,692		1,676	1,704
Total noncurrent liabilities	6,430		6,333	7,044
Common stock	7		7	7
Additional Paid in Capital	27,844		27,851	27,760
Retained earnings	487		250	750
Accumulated Other Comprehensive Income (Loss), Net of Tax	(2,739)		(2,806)	(2,821)
Total stockholders' equity attributable to the company	25,599		25,302	25,696
Noncontrolling Interests	240		239	240
Total Equity	25,839		25,541	25,936
Liabilities and Equity	45,500		42,618	42,633
EID [Member]
Cash and cash equivalents	1,646		3,190	2,031
Marketable Securities	85		124	290
Accounts and notes receivable - net	8,678		5,701	7,275
Inventories	6,585		6,812	4,986
Other current assets	1,335		968	1,296
Total current assets	18,329		16,795	15,878
Investments in nonconsolidated affiliates	87		102	91
Property, Plant and Equipment	8,633		8,551	8,483
Less: Accumulated Depreciation	4,362		4,297	4,150
Net Property, Plant and Equipment	4,271		4,254	4,333
Goodwill	10,508		9,962	10,109
Other intangible assets	10,137		9,339	9,865
Deferred Income Taxes	508		479	471
Other assets	1,660		1,687	1,886
Total Assets	45,500		42,618	42,633
Short-term borrowings and finance lease obligations	3,787		24	1,018
Accounts payable	3,957		4,895	3,685
Income Taxes Payable	298		183	180
Deferred Revenue	2,712		3,388	2,435
Accrued and other current liabilities	2,496		2,258	2,347
Total current liabilities	13,250		10,748	9,665
Long-term Debt	1,241		1,283	1,154
Long-term debt - related parties	429		789	1,825
Deferred income tax liabilities	1,255		1,119	1,203
Pension and other post employment benefits - noncurrent	2,242		2,255	2,983
Other noncurrent obligations	1,692		1,675	1,704
Total noncurrent liabilities	6,859		7,121	8,869
Common stock	0		0	0
Additional Paid in Capital	24,275		24,284	24,202
Retained earnings	3,614		3,031	2,478
Accumulated Other Comprehensive Income (Loss), Net of Tax	(2,739)		(2,806)	(2,821)
Total stockholders' equity attributable to the company	25,389		24,748	24,098
Noncontrolling Interests	2		1	1
Total Equity	25,391		24,749	24,099
Liabilities and Equity	45,500		42,618	42,633
EID [Member] | $4.50 Series Preferred Stock [Member]
Preferred Stock	169		169	169
EID [Member] | $3.50 Series Preferred Stock [Member]
Preferred Stock	$ 70		$ 70	$ 70
[1]Includes the intangible assets acquired in connection with the Stoller and Symborg acquisitions, which were completed on March 1, 2023. See Note 3 – Business Combinations, to the interim Consolidated Financial Statements, for additional information.

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01
Common Stock, Shares Authorized	1,666,667,000	1,666,667,000	1,666,667,000
Common Stock, Shares, Outstanding	710,678,000	713,419,000	725,320,000
EID [Member]
Common Stock, Par Value	$ 0.30	$ 0.30	$ 0.30
Common Stock, Shares Authorized	1,800,000,000	1,800,000,000	1,800,000,000
Common Stock, Shares, Outstanding	200	200	200
EID [Member] | $4.50 Series Preferred Stock [Member]
Preferred Stock, Par Value	$ 0	$ 0	$ 0
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	1,673,000	1,673,000	1,673,000
Preferred Stock, Redemption Amount	$ 120	$ 120	$ 120
EID [Member] | $3.50 Series Preferred Stock [Member]
Preferred Stock, Par Value	$ 0	$ 0	$ 0
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	700,000	700,000	700,000
Preferred Stock, Redemption Amount	$ 102	$ 102	$ 102

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Cash provided by (used for) operating activities
Net income		$ 599	$ 567
Provision for (benefit from) Deferred Income Tax		(85)	(37)
Net Periodic Pension and OPEB benefit, net		36	(71)
Pension and OPEB Contributions		(50)	(55)
Net loss (gain) on sales of property, businesses, consolidated companies, and investments		1	3
Restructuring and Asset related charges, net		33	5
Other net loss		48	104
Accounts and notes receivable		(2,708)	(2,372)
Inventories		324	234
Accounts Payable		(908)	(406)
Deferred Revenue		(685)	(782)
Other Assets and Liabilities		(203)	(227)
Cash provided by (used for) operating activities		(3,311)	(2,730)
Cash provided by (used for) investing activities
Capital expenditures		(151)	(179)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested		21	5
Payments to Acquire Businesses, Net of Cash Acquired		(1,463)	0
Investments in and loans to nonconsolidated affiliates		0	(6)
Purchases of investments		0	(234)
Proceeds from Sale and Maturities of Investments		40	10
Proceeds from Hedge, Investing Activities		42	0
Cash provided by (used for) investing activities		(1,511)	(404)
Cash provided by (used for) financing activities
Net change in borrowings (less than 90 days)		3,084	744
Proceeds from debt		626	311
Payments on Debt		(56)	0
Repurchase of Common Stock		(252)	(235)
Proceeds from Exercise of Stock Options		7	40
Dividends paid to stockholders		(107)	(102)
Other financing activities		(28)	(44)
Cash provided by (used for) financing activities		3,274	714
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash		(2)	(31)
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash		(1,550)	(2,451)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period		3,618	4,836
Cash, Cash Equivalents and Restricted Cash at End of Period	[1]	2,068	2,385
EID [Member]
Cash provided by (used for) operating activities
Net income		589	560
Provision for (benefit from) Deferred Income Tax		(85)	(37)
Net Periodic Pension and OPEB benefit, net		36	(71)
Pension and OPEB Contributions		(50)	(55)
Net loss (gain) on sales of property, businesses, consolidated companies, and investments		1	3
Restructuring and Asset related charges, net		33	5
Other net loss		48	104
Accounts and notes receivable		(2,708)	(2,372)
Inventories		324	234
Accounts Payable		(908)	(406)
Deferred Revenue		(685)	(782)
Other Assets and Liabilities		(188)	(217)
Cash provided by (used for) operating activities		(3,306)	(2,727)
Cash provided by (used for) investing activities
Capital expenditures		(151)	(179)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested		21	5
Payments to Acquire Businesses, Net of Cash Acquired		(1,463)	0
Investments in and loans to nonconsolidated affiliates		0	(6)
Purchases of investments		0	(234)
Proceeds from Sale and Maturities of Investments		40	10
Proceeds from Hedge, Investing Activities		42	0
Cash provided by (used for) investing activities		(1,511)	(404)
Cash provided by (used for) financing activities
Net change in borrowings (less than 90 days)		3,084	744
Proceeds from Related Party Debt		0	0
Repayments of Related Party Debt		(361)	(337)
Proceeds from debt		626	311
Payments on Debt		(56)	0
Proceeds from Exercise of Stock Options		7	40
Other financing activities		(31)	(47)
Cash provided by (used for) financing activities		3,269	711
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash		(2)	(31)
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash		(1,550)	(2,451)
Cash, Cash Equivalents and Restricted Cash at Beginning of Period		3,618	4,836
Cash, Cash Equivalents and Restricted Cash at End of Period		2,068	2,385
Total company [Member]
Cash provided by (used for) operating activities
Depreciation and Amortization		287	307
Restructuring and Asset related charges, net		33	5
Total company [Member] | EID [Member]
Cash provided by (used for) operating activities
Depreciation and Amortization		287	307
Restructuring and Asset related charges, net		$ 33	$ 5
[1]See page 16 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.

Statement of Stockholders Equit

Statement of Stockholders Equity Statement - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comp (Loss) Income	Noncontrolling Interest [Member]	EID [Member]	EID [Member] Preferred Stock [Member]	EID [Member] Common Stock [Member]	EID [Member] Additional Paid-in Capital [Member]	EID [Member] Retained Earnings [Member]	EID [Member] Accumulated Other Comp (Loss) Income	EID [Member] Noncontrolling Interest [Member]
Beginning Balance at Dec. 31, 2021	$ 25,623	$ 7	$ 27,751	$ 524	$ (2,898)	$ 239	$ 23,459	$ 239	$ 0	$ 24,196	$ 1,922	$ (2,898)	$ 0
Net income (loss)	567			564		3	560				559		1
Other comprehensive (loss) income	77				77		77					77
Common Dividends	102			(102)
Dividends, Preferred Stock							(2)				2
Issuance of Corteva Stock	40		40				40			40
Share-based compensation	(31)		(31)				(31)			(31)
Repurchase of common stock	(235)			(235)
Other-net	(3)			(1)		(2)	(4)			(3)	(1)
Ending Balance at Mar. 31, 2022	25,936	7	27,760	750	(2,821)	240	24,099	239	0	24,202	2,478	(2,821)	1
Beginning Balance at Dec. 31, 2022	25,541	7	27,851	250	(2,806)	239	24,749	239	0	24,284	3,031	(2,806)	1
Net income (loss)	599			595		4	589				588		1
Other comprehensive (loss) income	67				67		67					67
Common Dividends	107			(107)
Dividends, Preferred Stock							(3)				(3)
Issuance of Corteva Stock	7		7				7			7
Share-based compensation	(14)		(14)				(14)			(14)
Repurchase of common stock	(252)			(252)
Other-net	(2)			1		(3)	(4)			(2)	(2)
Ending Balance at Mar. 31, 2023	$ 25,839	$ 7	$ 27,844	$ 487	$ (2,739)	$ 240	$ 25,391	$ 239	$ 0	$ 24,275	$ 3,614	$ (2,739)	$ 2

Statement of Stockholders' Equi

Statement of Stockholders' Equity Parentheticals (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Common Stock, Dividends, Per Share, Declared	$ 0.15	$ 0.14
EID [Member] | $4.50 Series Preferred Stock [Member]
Preferred Stock, Dividends Per Share, Declared	1.125	1.125
EID [Member] | $3.50 Series Preferred Stock [Member]
Preferred Stock, Dividends Per Share, Declared	$ 0.875	$ 0.875

Summary of Significant Accounti

Summary of Significant Accounting Policies (Notes)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. Results for interim periods should not be considered indicative of results for a full year. These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2022, collectively referred to as the “2022 Annual Report.” The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained. Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 5 percent to both the company's annual net sales and segment operating EBITDA. We remeasure net monetary assets and translate our financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 – Supplementary Information, to the interim Consolidated Financial Statements and the company's 2022 Annual Report). As of March 31, 2023, a further 10 percent deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $10 million. We will continue to assess the implications to our operations and financial reporting.

Recent Accounting Guidance

Recent Accounting Guidance	3 Months Ended
	Mar. 31, 2023
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Guidance	RECENT ACCOUNTING GUIDANCE Recently Adopted Accounting GuidanceIn September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. This ASU includes amendments that require a buyer in supplier finance programs to disclose key terms of the programs and related obligations, including a rollforward of such obligations. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the rollforward requirements, which are effective for fiscal years beginning after December 15, 2023, and early adoption is permitted. Retrospective application to all periods in which a balance sheet is presented is required, except for the rollforward requirement, which will be applied prospectively. The company adopted this guidance on January 1, 2023 which resulted in certain disclosures being added relating to supplier financing programs and related obligations. See Note 13 – Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, for additional information.

Business Combinations and Asset

Business Combinations and Asset Acquisitions	3 Months Ended
	Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combination Disclosure	BUSINESS COMBINATIONS On March 1, 2023 ("Acquisition Date"), Corteva completed its previously announced acquisitions of all the outstanding equity interests in Stoller Group, Inc. (“Stoller”), one of the largest independent companies in the Biologicals industry, and Quorum Vital Investment, S.L. and its affiliates (“Symborg”), an expert in microbiological technologies. The purchase price for Stoller and Symborg was $1,224 million, subject to a working capital adjustment, and $370 million, respectively. These acquisitions supplement the crop protection business with additional biological tools that complement evolving farming practices. The operating results of Stoller and Symborg, since the Acquisition Date, did not have a material impact to the company's interim Consolidated Financial Statements for the three months ended March 31, 2023. Additionally, supplemental pro forma information have not been presented since the reported amounts in the company's interim Consolidated Financial Statements for the current period and comparative prior period would not be materially different had these acquisitions occurred as of January 1, 2022. Purchase Price Allocation The company performed a preliminary purchase price allocation and assessment of the fair value of the assets acquired and liabilities assumed as of the Acquisition Date. Due to the timing of the acquisitions, at March 31, 2023, the company continues to evaluate aspects of net working capital, acquired intangible assets, and property, plant and equipment. The company will finalize the purchase price allocation as it obtains the information necessary to complete the valuation during the measurement period. The effect of measurement period adjustments to the estimated fair values will be reflected as if the adjustments had been completed on the Acquisition Date. The following table summarizes the preliminary purchase price allocation to the assets acquired and liabilities assumed for the Stoller and Symborg acquisitions, as of the Acquisition Date: (In millions) Stoller Symborg Assets Cash and cash equivalents $ 95 $ — Accounts and notes receivable 238 16 Inventories 86 10 Other current assets 26 1 Property, plant and equipment 51 3 Goodwill 381 138 Other intangible assets 655 298 Deferred income taxes 7 — Other assets 8 2 Total assets acquired $ 1,547 $ 468 Liabilities Short-term borrowings 59 — Accounts payable 25 12 Income taxes payable 2 — Accrued and other current liabilities 60 12 Long-term debt 3 — Deferred income tax liabilities 154 74 Other noncurrent obligations 20 — Total liabilities assumed $ 323 $ 98 Net assets acquired $ 1,224 $ 370 The significant fair value adjustments included in the preliminary purchase price allocation are discussed below. Inventories Acquired inventories in connection with the acquisition of Stoller and Symborg are primarily comprised of finished goods and raw materials. The fair value of finished goods was calculated as the estimated selling price, adjusted for costs of the selling effort and a reasonable profit allowance relating to the selling effort. The fair value of raw materials and supplies was determined based on replacement cost which approximates historical carrying value. The fair value step-up will be recognized to cost of goods sold in the interim Consolidated Statements of Operations as the inventory is sold. Property, Plant & Equipment Property, plant and equipment associated with Stoller is comprised of $25 million of machinery and equipment, $19 million of buildings, $5 million of land and land improvements, and $2 million of construction in progress. The preliminary estimated fair value was primarily determined using a market approach for land and certain types of equipment, and a replacement cost approach for the remaining depreciable property, plant and equipment. The market approach for certain types of equipment represents a sale comparison that measures the value of an asset through an analysis of sales and offerings of comparable assets. The replacement cost approach used for all other depreciable property, plant and equipment measures the value of an asset by estimating the cost to acquire or construct comparable assets and adjust for age and condition of the asset. Goodwill The excess of the consideration for Stoller and Symborg over the preliminary net fair value of assets acquired and liabilities assumed resulted in the recognition of goodwill, which has been assigned to the crop protection reporting unit. Goodwill associated with these acquisitions is attributable to the assembled workforce and expanding the company’s addressable market position. None of the goodwill recognized will be deductible for income tax purposes. Other Intangible Assets In connection with the acquisitions of Stoller and Symborg, the company recorded certain intangible assets, as shown in the table below, representing the preliminary fair values at the Acquisition Date. Intangible Assets Stoller Symborg (In millions) Fair Value Weighted-Average Amortization Period (Years) Fair Value Weighted-Average Amortization Period (Years) Intangible assets with finite lives: Customer-related $ 491 13 $ — — Developed technology 121 14 229 12 Trademarks/trade names 43 15 55 12 Total intangible assets with finite lives 655 13 284 12 Intangible assets with infinite lives: IPR&D — — 14 — Total intangible assets with infinite lives — — 14 — Total intangible assets $ 655 $ 298

Revenue (Notes)

Revenue (Notes)	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer	REVENUE Revenue Recognition Products Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years. Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. When the company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to or at shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less. The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price primarily utilize the expected value method based on historical experience. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances. Licenses of Intellectual Property Corteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain sales-based royalties is recognized at the later of (i) when the subsequent sale occurs or (ii) when the performance obligation to which some or all of the royalty has been allocated is satisfied. Remaining Performance Obligations Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of more than one year. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $126 million, $131 million and $120 million at March 31, 2023, December 31, 2022 and March 31, 2022, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over the period of one year to six years. Contract Balances Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract Balances March 31, 2023 December 31, 2022 March 31, 2022 (In millions) Accounts and notes receivable - trade 1 $ 7,334 $ 4,261 $ 6,029 Contract assets - current 2 $ 26 $ 26 $ 24 Contract assets - noncurrent 3 $ 63 $ 64 $ 58 Deferred revenue - current $ 2,712 $ 3,388 $ 2,435 Deferred revenue - noncurrent 4 $ 103 $ 107 $ 104 1. Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets. 2. Included in other current assets in the interim Consolidated Balance Sheets. 3. Included in other assets in the interim Consolidated Balance Sheets. 4. Included in other noncurrent obligations in the interim Consolidated Balance Sheets. Revenue recognized during the three months ended March 31, 2023 and 2022 from amounts included in deferred revenue at the beginning of the period was $1,201 million and $1,339 million, respectively. Disaggregation of Revenue Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below: Three Months Ended (In millions) 2023 2022 Corn $ 1,979 $ 1,930 Soybean 269 172 Other oilseeds 301 277 Other 146 145 Seed 2,695 2,524 Herbicides 1,242 1,205 Insecticides 409 418 Fungicides 359 304 Other 179 150 Crop Protection 2,189 2,077 Total $ 4,884 $ 4,601 Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below: Seed Three Months Ended (In millions) 2023 2022 North America 1 $ 1,323 $ 1,184 EMEA 2 1,012 926 Latin America 259 323 Asia Pacific 101 91 Total $ 2,695 $ 2,524 Crop Protection Three Months Ended (In millions) 2023 2022 North America 1 $ 879 $ 821 EMEA 2 801 656 Latin America 293 327 Asia Pacific 216 273 Total $ 2,189 $ 2,077 1. Represents U.S. & Canada. 2. Europe, Middle East, and Africa ("EMEA").

Restructuring and Asset Related

Restructuring and Asset Related Charges	3 Months Ended
	Mar. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	RESTRUCTURING AND ASSET RELATED CHARGES - NET 2022 Restructuring Actions In connection with the company’s shift to a global business unit model during 2022, the company assessed its business priorities and operational structure to maximize the customer experience and deliver on growth and earnings potential. As a result of this assessment, the company committed to restructuring actions during the second quarter of 2022 that, when combined with the impact of the company’s separate announcement to withdraw from Russia (“Russia Exit”) (collectively the “2022 Restructuring Actions”), is expected to result in total net pre-tax restructuring and other charges of $350 million to $420 million, comprised of $105 million to $120 million of severance and related benefit costs, $125 million to $150 million of asset related charges, $65 million to $80 million of costs related to contract terminations (including early lease terminations) and $55 million to $70 million of other charges. Through the first quarter of 2023, the company recorded net pre-tax restructuring and other charges of $341 million, comprised of $115 million of severance and related benefit costs, $111 million of asset related charges, $57 million of costs related to contract terminations (including early lease terminations) and $58 million of other charges. Cash payments related to these charges are anticipated to be $180 million to $210 million, of which approximately $115 million has been paid through March 31, 2023, and primarily relate to the payment of severance and related benefits, contract terminations and other charges. The restructuring actions associated with these charges are expected to be substantially complete in 2023. The total net pre-tax restructuring and other charges recognized through the first quarter of 2023 included $49 million associated with the Russia Exit. The Russia Exit net pre-tax restructuring charges consisted of $6 million of severance and related benefit costs, $6 million of asset related charges, and $26 million of costs related to contract terminations (including early lease terminations). Other pre-tax charges associated with the Russia Exit were recorded to cost of goods sold and other income (expense) – net in the interim Consolidated Statement of Operations, relating to inventory write-offs of $3 million and settlement costs of $8 million, respectively. The charges related to the 2022 Restructuring Actions related to the segments, as well as corporate expenses, for the three months ended March 31, 2023 were as follows: Three Months Ended March 31, 2023 (In millions) Seed $ 6 Crop Protection 1 Corporate expenses 4 Total 1 $ 11 1. This amount excludes other pre-tax charges recorded during the three months ended March 31, 2023 impacting the Seed segment included in cost of goods sold and other income (expense) - net, in the company's interim Consolidated Statement of Operations, relating to inventory write-offs and the loss on the sale of the company's interest in an equity investment. The following table is a summary of charges incurred related to 2022 Restructuring Actions for the three months ended March 31, 2023: Three Months Ended March 31, 2023 (In millions) Severance and related benefit costs $ 4 Asset related charges 7 Contract termination charges 1 — Total restructuring and asset related charges - net 2 $ 11 1. Contract terminations includes early lease terminations. 2. This amount excludes other pre-tax charges recorded during the three months ended March 31, 2023 included in cost of goods sold and other income (expense) - net, in the company's interim Consolidated Statement of Operations, relating to inventory write-offs and the loss on the sale of the company's interest in an equity investment. A reconciliation of the December 31, 2022 to the March 31, 2023 liability balances related to the 2022 Restructuring Actions is summarized below: (in millions) Severance and Related Benefit Costs Asset Related Contract Termination 1 Total Balance at December 31, 2022 $ 71 $ — $ 12 $ 83 Charges to income (loss) from continuing operations 4 7 — 11 Payments (12) — (11) (23) Asset write-offs — (7) — (7) Balance at March 31, 2023 $ 63 $ — $ 1 $ 64 1. The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by the end of 2023. Other Asset Related Charges The company recognized $16 million and $6 million for the three months ended March 31, 2023 and 2022, respectively, in restructuring and asset related charges - net in the interim Consolidated Statement of Operations, from non-cash accelerated prepaid royalty amortization expense related to Roundup Ready 2 Yield® and Roundup Ready 2 Xtend® herbicide tolerance traits.

Supplementary Information

Supplementary Information	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Additional Financial Information Disclosure [Text Block]	SUPPLEMENTARY INFORMATION Other Income (Expense) - Net Three Months Ended (In millions) 2023 2022 Interest income $ 40 $ 15 Equity in earnings (losses) of affiliates - net 3 10 Net gain (loss) on sales of businesses and other assets (1) (3) Net exchange gains (losses) 1 (36) (47) Non-operating pension and other post employment benefit credit (costs) 2 (31) 75 Miscellaneous income (expenses) - net 3 (46) (33) Other income (expense) - net $ (71) $ 17 1. Includes net pre-tax exchange gains (losses) of $(21) million and $(15) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2023 and 2022, respectively. 2. Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 3. Miscellaneous income (expenses) - net for the three months ended March 31, 2023 and 2022 includes estimated settlement reserves, gains on the sale of assets, a loss on the sale of the company’s interest in an equity investment, and other items. Additionally, the three months ended March 31, 2022 includes losses associated with a previously held equity investment. The following table summarizes the impacts of the company's foreign currency hedging program on the company's results of operations. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the U.S., whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income (expense) - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the interim Consolidated Statements of Operations. (In millions) Three Months Ended 2023 2022 Subsidiary Monetary Position Gain (Loss) Pre-tax exchange gain (loss) $ (30) $ 6 Local tax (expenses) benefits 9 (4) Net after-tax impact from subsidiary exchange gain (loss) $ (21) $ 2 Hedging Program Gain (Loss) Pre-tax exchange gain (loss) $ (6) $ (53) Tax (expenses) benefits 2 13 Net after-tax impact from hedging program exchange gain (loss) $ (4) $ (40) Total Exchange Gain (Loss) Pre-tax exchange gain (loss) $ (36) $ (47) Tax (expenses) benefits 11 9 Net after-tax exchange gain (loss) $ (25) $ (38) Cash, cash equivalents and restricted cash equivalents The following table provides a reconciliation of cash and cash equivalents and restricted cash equivalents presented in the interim Consolidated Balance Sheets to the total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows. Corteva classifies restricted cash equivalents as current or noncurrent based on the nature of the restrictions, which are included in other current assets and other assets, respectively, in the interim Consolidated Balance Sheets. (In millions) March 31, 2023 December 31, 2022 March 31, 2022 Cash and cash equivalents $ 1,646 $ 3,191 $ 2,031 Restricted cash equivalents 422 427 354 Total cash, cash equivalents and restricted cash equivalents $ 2,068 $ 3,618 $ 2,385 Restricted cash equivalents primarily relates to a trust funded by EIDP for cash obligations under certain non-qualified benefit and deferred compensation plans due to the Merger, which was a change in control event, and contributions to escrow accounts established for the settlement of certain legal matters, which is classified as current, and the settlement of legacy PFAS matters and the associated qualified spend, which is classified as noncurrent.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	INCOME TAXES The effective tax rate for the three months ended March 31, 2023 and 2022 was 21.8% and 17.3%, respectively. During the three months ended March 31, 2023, the company recognized $12 million of net tax benefits for income taxes on continuing operations associated with changes in deferred taxes and accruals for certain prior year tax positions in various jurisdictions as well as from stock-based compensation. During the three months ended March 31, 2022, the company recognized $35 million of net tax benefits for income taxes on continuing operations associated with changes in deferred taxes for certain prior year tax positions as well as from stock-based compensation. The company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of the program, which resides in the U.S., is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions, which can drive material impacts on the company's effective tax rate. For further discussion of pre-tax and after-tax impacts of the company's foreign currency hedging program and net monetary asset programs, refer to Note 6 - Supplementary Information.

Earnings Per Share (Notes)

Earnings Per Share (Notes)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	EARNINGS PER SHARE OF COMMON STOCK The following tables provide earnings per share calculations for the periods indicated below: Net Income (Loss) for Earnings (Loss) Per Share Calculations - Basic and Diluted Three Months Ended (In millions) 2023 2022 Income (loss) from continuing operations after income taxes $ 607 $ 577 Net income (loss) attributable to continuing operations noncontrolling interests 4 3 Income (loss) from continuing operations available to Corteva common stockholders 603 574 (Loss) income from discontinued operations available to Corteva common stockholders (8) (10) Net income (loss) available to common stockholders $ 595 $ 564 Earnings (Loss) Per Share Calculations - Basic Three Months Ended (Dollars per share) 2023 2022 Earnings (loss) per share of common stock from continuing operations $ 0.85 $ 0.79 (Loss) earnings per share of common stock from discontinued operations (0.01) (0.01) Earnings (loss) per share of common stock $ 0.84 $ 0.78 Earnings (Loss) Per Share Calculations - Diluted Three Months Ended (Dollars per share) 2023 2022 Earnings (loss) per share of common stock from continuing operations $ 0.84 $ 0.79 (Loss) earnings per share of common stock from discontinued operations (0.01) (0.01) Earnings (loss) per share of common stock $ 0.83 $ 0.78 Share Count Information Three Months Ended (Shares in millions) 2023 2022 Weighted-average common shares - basic 712.9 727.0 Plus dilutive effect of equity compensation plans 1 3.3 3.9 Weighted-average common shares - diluted 716.2 730.9 Potential shares of common stock excluded from EPS calculations 2 2.7 2.5 1. Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect. 2. These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Accounts and Notes Receivable (

Accounts and Notes Receivable (Notes)	3 Months Ended
	Mar. 31, 2023
Accounts and Notes Receivable [Abstract]
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	ACCOUNTS AND NOTES RECEIVABLE - NET (In millions) March 31, 2023 December 31, 2022 March 31, 2022 Accounts receivable – trade 1 $ 6,883 $ 4,168 $ 5,603 Notes receivable – trade 1,2 451 93 426 Other 3 1,344 1,440 1,246 Total accounts and notes receivable - net $ 8,678 $ 5,701 $ 7,275 1. Accounts receivable – trade and notes receivable - trade are net of allowances of $207 million, $194 million, and $232 million at March 31, 2023, December 31, 2022, and March 31, 2022, respectively. 2. Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of March 31, 2023, December 31, 2022, and March 31, 2022 there were no significant impairments related to current loan agreements. 3. Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 5 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $137 million, $148 million, and $124 million as of March 31, 2023, December 31, 2022, and March 31, 2022, respectively. Accounts and notes receivable are carried at the expected amount to be collected, which approximates fair value. The company establishes the allowance for doubtful receivables using a loss-rate method where the loss rate is developed using past events, historical experience, current conditions and forecasts that affect the collectability of the financial assets. The following table summarizes changes in the allowance for doubtful receivables for the three months ended March 31, 2023 and 2022: (In millions) 2022 Balance at December 31, 2021 $ 210 Net provision for credit losses 5 Write-offs charged against allowance / other 17 Balance at March 31, 2022 $ 232 2023 Balance at December 31, 2022 $ 194 Net provision for credit losses 10 Write-offs charged against allowance / other 3 Balance at March 31, 2023 $ 207 The company enters into various factoring agreements with third-party financial institutions to sell its trade receivables under both recourse and non-recourse agreements in exchange for cash proceeds. These financing arrangements result in a transfer of the company's receivables and risks to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are derecognized from the interim Consolidated Balance Sheets upon transfer, and the company receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, which is typically provided through a guarantee of accounts in the event of customer default, the guarantee obligation is measured using market data from similar transactions and reported as a current liability in the interim Consolidated Balance Sheets. Trade receivables sold under these agreements were $8 million and $17 million for the three months ended March 31, 2023 and 2022, respectively. The trade receivables sold that remained outstanding under these agreements which include an element of recourse as of March 31, 2023, December 31, 2022, and March 31, 2022 were $19 million, $37 million, and $130 million, respectively. The net proceeds received are included in cash provided by (used for) operating activities in the interim Consolidated Statements of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in other income (expense) - net in the interim Consolidated Statements of Operations. The loss on sale of receivables for the three months ended March 31, 2023 and 2022 was not material. See Note 13 - Commitments and Contingent Liabilities for additional information on the company’s guarantees.

Inventories

Inventories	3 Months Ended
	Mar. 31, 2023
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	INVENTORIES (In millions) March 31, 2023 December 31, 2022 March 31, 2022 Finished products $ 3,650 $ 3,260 $ 2,691 Semi-finished products 2,023 2,689 1,635 Raw materials and supplies 912 862 660 Total inventories $ 6,585 $ 6,811 $ 4,986

Other Intangible Assets

Other Intangible Assets	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill The following table summarizes changes in the carrying amount of goodwill by segment for the three months ended March 31, 2023: (In millions) Crop Protection Seed Total Balance as of December 31, 2022 $ 4,618 $ 5,344 $ 9,962 Acquisitions 1 519 — 519 Currency translation adjustments 13 14 27 Balance as of March 31, 2023 $ 5,150 $ 5,358 $ 10,508 1. On March 1, 2023, the company completed the acquisitions of Stoller and Symborg, which are included in the crop protection segment. See Note 3 – Business Combinations, to the interim Consolidated Financial Statements, for additional information. Other Intangibles Assets The gross carrying amounts and accumulated amortization of other intangible assets by major class are as follows: (In millions) March 31, 2023 1 December 31, 2022 March 31, 2022 Gross Accumulated Net Gross Accumulated Net Gross Accumulated Net Intangible assets subject to amortization (Definite-lived): Germplasm $ 6,291 $ (890) $ 5,401 $ 6,291 $ (826) $ 5,465 $ 6,265 $ (634) $ 5,631 Customer-related 2,407 (617) 1,790 1,912 (585) 1,327 1,953 (515) 1,438 Developed technology 1,845 (868) 977 1,485 (830) 655 1,485 (716) 769 Trademarks/trade names 2,107 (271) 1,836 2,009 (251) 1,758 2,011 (192) 1,819 Favorable supply contracts 2 475 (420) 55 Other 3 395 (276) 119 395 (271) 124 405 (262) 143 Total other intangible assets with finite lives 13,045 (2,922) 10,123 12,092 (2,763) 9,329 12,594 (2,739) 9,855 Intangible assets not subject to amortization (Indefinite-lived): IPR&D 14 — 14 10 — 10 10 — 10 Total other intangible assets 14 — 14 10 — 10 10 — 10 Total $ 13,059 $ (2,922) $ 10,137 $ 12,102 $ (2,763) $ 9,339 $ 12,604 $ (2,739) $ 9,865 1. Includes the intangible assets acquired in connection with the Stoller and Symborg acquisitions, which were completed on March 1, 2023. See Note 3 – Business Combinations, to the interim Consolidated Financial Statements, for additional information. 2. Effective November 1, 2022, the favorable supply contracts expired and were fully amortized. 3. Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements. The aggregate pre-tax amortization expense from continuing operations for definite-lived intangible assets was $160 million and $179 million for the three months ended March 31, 2023 and 2022, respectively. The current estimated aggregate pre-tax amortization expense from continuing operations for the remainder of 2023 and each of the next five years is approximately $520 million, $679 million, $642 million, $631 million, $571 million and $549 million, respectively.

Short-Term Borrowings, Long-Ter

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	SHORT-TERM BORROWINGS, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES The following tables summarize Corteva's short-term borrowings and finance lease obligations and long-term debt: Short-term borrowings and finance lease obligations (In millions) March 31, 2023 December 31, 2022 March 31, 2022 Commercial paper $ 2,680 $ — $ 984 364-Day Revolving Credit Facility 1,000 — — Other loans - various currencies 57 23 33 Long-term debt payable within one year 49 — — Finance lease obligations payable within one year 1 1 1 Total short-term borrowings and finance lease obligations $ 3,787 $ 24 $ 1,018 Long-term debt (in millions) March 31, 2023 December 31, 2022 March 31, 2022 Amount Weighted Average Rate Amount Weighted Average Rate Amount Weighted Average Rate Promissory notes and debentures: Maturing in 2025 $ 500 1.70 % $ 500 1.70 % $ 500 1.70 % Maturing in 2030 500 2.30 % 500 2.30 % 500 2.30 % Other loans: Foreign currency loans, various rates and maturities 187 14.80 % 181 14.80 % 53 15.00 % Medium-term notes, varying maturities through 2041 107 4.62 % 107 4.27 % 107 0.35 % Finance lease obligations 3 2 3 Less: Unamortized debt discount and issuance costs 7 7 9 Less: Long-term debt due within one year 49 — — Total long-term debt $ 1,241 $ 1,283 $ 1,154 The estimated fair value of the company's short-term and long-term borrowings, including interest rate financial instruments, was determined using Level 2 inputs within the fair value hierarchy. Based on quoted market prices for the same or similar issues, or on current rates offered to the company for debt of the same remaining maturities, the fair value of the company's short-term borrowings and finance lease obligations was approximately carrying value. The fair value of the company’s long-term borrowings, including debt due within one year, was $1,198 million, $1,172 million, and $1,107 million as of March 31, 2023, December 31, 2022, and March 31, 2022, respectively. Foreign Currency Loans The company enters into short-term and long-term foreign currency loans from time-to-time by accessing uncommitted revolving credit lines to fund working capital needs of foreign subsidiaries in the normal course of business (“Foreign Currency Loans”). Interest rates are variable and determined at the time of borrowing. Total unused bank credit lines on the Foreign Currency Loans at March 31, 2023 was approximately $75 million. The company’s long-term Foreign Currency Loans have varying maturities through 2024. Available Committed Credit Facilities The following table summarizes the company's credit facilities: Committed and Available Credit Facilities at March 31, 2023 (in millions) Effective Date Committed Credit Credit Available Maturity Date Interest Revolving Credit Facility May 2022 $ 3,000 $ 3,000 May 2027 Floating Rate Revolving Credit Facility May 2022 2,000 2,000 May 2025 Floating Rate 364-day Revolving Credit Facility May 2022 1,000 — January 2024 Floating Rate Total Committed and Available Credit Facilities $ 6,000 $ 5,000 Revolving Credit Facilities In May 2022, EIDP entered into a $3 billion, 5-year revolving credit facility and a $2 billion, 3-year revolving credit facility (the “Revolving Credit Facilities”) expiring in May 2027 and May 2025, respectively. Borrowings under the Revolving Credit Facilities will have an interest rate equal to Adjusted Term SOFR, which is Term SOFR plus 0.10 percent, plus the applicable margin. The Revolving Credit Facilities may serve as a substitute to the company's commercial paper program, and can be used, from time to time, for general corporate purposes including, but not limited to, the funding of seasonal working capital needs. The Revolving Credit Facilities contain customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the Revolving Credit Facilities contain a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60. At March 31, 2023, the company was in compliance with these covenants. 364-Day Revolving Credit Facilities In May 2022, as amended in January 2023, the company entered into a $1 billion, 364-day revolving credit agreement (the “364-Day Revolving Credit Facility”) expiring in January 2024. Borrowings under the 364-Day Revolving Credit Facility will have an interest rate equal to Adjusted Term SOFR, which is Term SOFR plus 0.10 percent, plus the applicable margin. The 364-Day Revolving Credit Facility includes a provision under which the company may convert any advances outstanding prior to the maturity date into term loans having a maturity date up to one year later. In February 2023, the company drew down $1 billion under the 364-Day Revolving Credit Facility, which was used for general corporate purposes, including funding seasonal working capital needs, capital spending, dividend payments, share repurchases and to partially fund the Stoller and Symborg acquisitions. The 364-Day Revolving Credit Facility contains customary representations and warranties, affirmative and negative covenants and events of default that are typical for companies with similar credit ratings. Additionally, the 364-Day Revolving Credit Facility contains a financial covenant requiring that the ratio of total indebtedness to total capitalization for Corteva and its consolidated subsidiaries not exceed 0.60. At March 31, 2023, the company was in compliance with these covenants.

Commitments and Contingent Liab

Commitments and Contingent Liabilities	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	COMMITMENTS AND CONTINGENT LIABILITIES Guarantees Indemnifications In connection with acquisitions and divestitures, the company has indemnified respective parties against certain liabilities that may arise in connection with these transactions and business activities prior to the completion of the transactions. The term of these indemnifications, which typically pertain to environmental, tax and product liabilities, is generally indefinite. In addition, the company indemnifies its duly elected or appointed directors and officers to the fullest extent permitted by Delaware law, against liabilities incurred as a result of their activities for the company, such as adverse judgments relating to litigation matters. If the indemnified party were to incur a liability or have a liability increase as a result of a successful claim, pursuant to the terms of the indemnification, the company would be required to reimburse the indemnified party. The maximum amount of potential future payments is generally unlimited. See below for additional information relating to the indemnification obligations under the Chemours Separation Agreement and the Corteva Separation Agreement. Obligations for Supplier Finance Programs The company enters into supplier finance programs with various finance providers in which the company agrees to pay the stated amount of confirmed invoices from participating suppliers by the original maturity date. The company or the financial provider may terminate the agreement upon providing at least thirty days’ written notice. The payment terms that the company has with its finance providers under supplier finance programs are less than one year. At March 31, 2023, December 31, 2022 and March 31, 2022, the outstanding obligations under supplier finance programs was approximately $165 million, $220 million, and $180 million, respectively, and included within accounts payable in the interim Consolidated Balance Sheets. Obligations for Customers and Other Third Parties The company has directly guaranteed various debt obligations under agreements with third parties related to customers and other third parties. At March 31, 2023, December 31, 2022 and March 31, 2022, the company had directly guaranteed $79 million, $88 million, and $105 million, respectively, of such obligations. These amounts represent the maximum potential amount of future (undiscounted) payments that the company could be required to make under the guarantees in the event of default by the guaranteed party. Of the maximum future payments at March 31, 2023, approximately $15 million had terms greater than one year. The maximum future payments include $9 million, $16 million and $21 million at March 31, 2023, December 31, 2022 and March 31, 2022, respectively, of guarantees related to the various factoring agreements that the company enters into with third-party financial institutions to sell its trade receivables. See Note 9 - Accounts and Notes Receivable - Net, to the interim Consolidated Financial Statements, for additional information. The maximum future payments also include agreements with lenders to establish programs that provide financing for select customers. The terms of the guarantees are equivalent to the terms of the customer loans that are primarily made to finance customer invoices. The total amounts owed from customers to the lenders relating to these agreements was $89 million, $202 million and $180 million at March 31, 2023, December 31, 2022 and March 31, 2022, respectively. The company assesses the payment/performance risk by assigning default rates based on the duration of the guarantees. These default rates are assigned based on the external credit rating of the counterparty or through internal credit analysis and historical default history for counterparties that do not have published credit ratings. For counterparties without an external rating or available credit history, a cumulative average default rate is used. Indemnifications under Separation Agreements The company has entered into various agreements where the company is indemnified for certain liabilities. The term of this indemnification is generally indefinite, with exceptions, and includes defense costs and expenses, as well as monetary and non-monetary settlements and judgments. In connection with the recognition of liabilities related to these matters, the company records an indemnification asset when recovery is deemed probable. Chemours/Performance Chemicals Pursuant to the Chemours Separation Agreement resulting from the 2015 spin-off of the Performance Chemicals segment from Historical DuPont, Chemours indemnifies the company against certain litigation, environmental, workers' compensation and other liabilities that arose prior to the distribution. In 2017, the Chemours Separation Agreement was amended to provide for a limited sharing of potential future liabilities related to alleged historical releases of perfluorooctanoic acids and its ammonium salts (“PFOA”) for a five-year period that began on July 6, 2017. In addition, in 2017, Chemours and EIDP settled multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”), resolving claims of about 3,550 plaintiffs alleging injury from exposure to PFOA in drinking water as a result of the historical manufacture or use of PFOA at the Washington Works plant outside Parkersburg, West Virginia. This plant was previously owned and/or operated by the performance chemicals segment of EIDP and is now owned and/or operated by Chemours. On May 13, 2019, Chemours filed suit in the Delaware Court of Chancery against DuPont, EIDP, and Corteva, seeking, among other things, to limit its responsibility for the litigation and environmental liabilities allocated to and assumed by Chemours under the Chemours Separation Agreement (the “Delaware Litigation”). On March 30, 2020, the Court of Chancery granted a motion to dismiss. On December 15, 2020, the Delaware Supreme Court affirmed the judgment of the Court of Chancery. Meanwhile, a confidential arbitration process regarding the same and other claims proceeded (the “Arbitration”). On January 22, 2021, Chemours, DuPont, Corteva and EIDP entered into a binding memorandum of understanding containing a settlement to resolve legal disputes originating from the Delaware Litigation and Arbitration, and to establish a cost sharing arrangement and escrow account to be used to support and manage potential future legacy per- and polyfluoroalkyl substances ("PFAS") liabilities arising out of pre-July 1, 2015 conduct (the “MOU”). The MOU replaces the 2017 amendment to the Chemours Separation Agreement. According to the terms of the cost sharing arrangement within the MOU, Corteva and DuPont together, on one hand, and Chemours, on the other hand, agreed to a 50-50 split of certain qualified expenses related to PFAS liabilities incurred over a term not to exceed twenty years or $4 billion of qualified spend and escrow account contributions (see below for discussion of the escrow account) in the aggregate. DuPont’s and Corteva’s 50% share under the MOU will be limited to $2 billion, including qualified expenses and escrow contributions. These expenses and escrow account contributions will be subject to the existing Letter Agreement, under which DuPont and Corteva will each bear 50% of the first $300 million (up to $150 million each), and thereafter DuPont bears 71% and Corteva bears the remaining 29%. Under the terms of the MOU, Corteva's estimated aggregate share of the potential $2 billion is approximately $600 million. In order to support and manage any potential future PFAS liabilities, the parties have also agreed to establish an escrow account ("MOU Escrow Account"). The MOU provides that (1) no later than each of September 30, 2021 and September 30, 2022, Chemours shall deposit $100 million into an escrow account and DuPont and Corteva shall together deposit $100 million in the aggregate into an escrow account and (2) no later than September 30 of each subsequent year through and including 2028, Chemours shall deposit $50 million into an escrow account and DuPont and Corteva shall together deposit $50 million in the aggregate into an escrow account. Subject to the terms and conditions set forth in the MOU, each party may be permitted to defer funding in any year (excluding 2021). Over this period, Chemours will deposit a total of $500 million in the account and DuPont and Corteva will deposit an additional $500 million pursuant to the terms of the Letter Agreement. Additionally, if on December 31, 2028, the balance of the escrow account (including interest) is less than $700 million, Chemours will make 50% of the deposits and DuPont and Corteva together will make 50% of the deposits necessary to restore the balance of the escrow account to $700 million, pursuant to the terms of the Letter Agreement. Such payments will be made in a series of consecutive annual equal installments commencing on September 30, 2029, pursuant to the escrow account replenishment terms as set forth in the MOU. The MOU provides that no withdrawals from the MOU Escrow Account can be made before year six, except to fund mutually agreed upon third-party settlements in excess of $125 million. Starting with year six, withdrawals can only be made to fund qualified spend if the parties’ aggregate qualified spend in that particular year is greater than $200 million. Beginning with year 11, the amounts in the MOU Escrow Account can be used to fund any qualified spend. The company made its annual installment deposits due to the MOU Escrow Account through March 31, 2023. These payments are classified as noncurrent restricted cash equivalents and included in other assets in the interim Consolidated Balance Sheets. After the term of this arrangement, Chemours’ indemnification obligations under the original 2015 Chemours Separation Agreement, would continue unchanged, subject in each case to certain exceptions set out in the MOU. Under the MOU, Chemours waived specified claims regarding the construct of its 2015 spin-off transaction, and the parties will dismiss the Pending Arbitration regarding those claims. Additionally, the parties have agreed to resolve the Ohio MDL PFOA personal injury litigation (as discussed below). The parties are expected to cooperate in good faith to enter into additional agreements reflecting the terms set forth in the MOU. Corteva Separation Agreement On April 1, 2019, in connection with the Dow Distribution, Corteva, DuPont and Dow entered into the Corteva Separation Agreement, the Tax Matters Agreement, the Employee Matters Agreement, and certain other agreements (collectively, the “Corteva Separation Agreements”). The Corteva Separation Agreements allocate among Corteva, DuPont and Dow assets, employees, certain liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) among the parties and provides for indemnification obligation among the parties. Under the Corteva Separation Agreements, DuPont will indemnify Corteva against certain litigation, environmental, tax, workers' compensation and other liabilities that arose prior to the Corteva Distribution and Dow indemnifies Corteva against certain litigation, environmental, tax, workers' compensation and other liabilities that relate to the Historical Dow business, and Corteva indemnifies DuPont and Dow for certain liabilities. Under the Corteva Separation Agreement, certain legacy EIDP liabilities from discontinued and/or divested operations and businesses of EIDP (including Performance Chemicals) (a “stray liability”) were allocated to Corteva or DuPont. For those stray liabilities allocated to Corteva (which may include a specified amount of liability associated with that liability), Corteva is responsible for liabilities in an amount up to that specified amount plus an additional $200 million and, for those stray liabilities allocated to DuPont (which may include a specified amount of liability associated with that liability), DuPont is responsible for liabilities up to a specified amount plus an additional $200 million. Once each company has met the $200 million threshold, Corteva and DuPont will share future liabilities proportionally on the basis of 29% and 71%, respectively; provided, however, that for PFAS, DuPont will manage such liabilities with Corteva and DuPont sharing the costs on a 50% - 50% basis starting from $1 and up to $300 million (with such amount, up to $150 million, to be credited to each company’s $200 million threshold) and once the $300 million threshold is met, then the companies will share proportionally on the basis of 29% and 71% respectively, subject to a $1 million de minimis requirement. The aggregate amount of cash remitted by Corteva has exceeded the stray liability thresholds, including PFAS, noted above. At March 31, 2023, December 31, 2022, and March 31, 2022, the indemnification assets were $36 million, $31 million, and $31 million, respectively, within accounts and notes receivable - net and $109 million, $105 million, and $80 million, respectively, within other assets in the interim Consolidated Balance Sheets. At March 31, 2023, December 31, 2022, and March 31, 2022, the indemnification liabilities were $32 million, $31 million, and $32 million, respectively, within accrued and other current liabilities and $118 million, $115 million, and $116 million, respectively, within other noncurrent obligations in the interim Consolidated Balance Sheets. Litigation The company is subject to various legal proceedings, including, but not limited to, product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters arising out of the normal course of its current businesses or legacy EIDP businesses unrelated to Corteva’s current businesses but allocated to Corteva as part of the separation of Corteva from DuPont. It is not possible to predict the outcome of these various proceedings, as considerable uncertainty exists. The company records accruals for legal matters when the information available indicates that it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Accruals may reflect the impact and status of negotiations, settlements, rulings, advice from counsel and other information and events that may pertain to a particular matter. For the litigation matters discussed below, management believes that it is reasonably possible that the company could incur liabilities in excess of amounts accrued, the ultimate liability for which could be material to the results of operations and the cash flows in the period recognized. However, the company is unable to estimate the possible loss beyond amounts accrued due to various reasons, including, among others, that the underlying matters are either in early stages and/or have significant factual issues to be resolved. In addition, even when the company believes it has substantial defenses, the company may consider settlement of matters if it believes it is in the best interest of the company. Lorsban ® Lawsuits As of March 31, 2023, there were pending personal injury lawsuits filed and additional asserted claims against the former Dow Agrosciences LLC, alleging injuries related to chlorpyrifos exposure, the active ingredient in Lorsban®, an insecticide used by commercial farms for field fruit, nut and vegetable crops. Corteva ended its production of Lorsban® in 2020. Chlorpyrifos products are restricted-use pesticides, which are not available for purchase or use by the general public, and may only be sold to, and used by, certified applicators or someone under the certified applicator's direct supervision. These lawsuits do not relate to Dursban®, a residential type chlorpyrifos product that was authorized for indoor purposes, which was discontinued over two decades ago prior to the Merger and Corteva’s formation and Separation. Claimants allege personal injury, including autism, developmental delays and/or decreased neurologic function, resulting from farm worker exposure and bystander drift and in utero exposure to chlorpyrifos. Certain claimants have also put forth remediation claims due to alleged property contamination from chlorpyrifos. As of March 31, 2023, an accrual has been established for the estimated resolution of certain claims. Federal Trade Commission Investigation On May 26, 2020, Corteva received a subpoena from the Federal Trade Commission (“FTC”) directing it to submit documents pertaining to its crop protection products generally, as well as business plans, rebate programs, offers, pricing and marketing materials specifically related to its acetochlor, oxamyl, rimsulfuron and other related products in order to determine whether Corteva engaged in unfair methods of competition through anticompetitive conduct. Corteva has fully cooperated with all requests related to this subpoena. On September 29, 2022, the FTC, along with ten state attorneys general in California, Colorado, Illinois, Indiana, Iowa, Minnesota, Nebraska, Oregon, Wisconsin, and Texas, filed a lawsuit against Corteva and another competitor alleging the parties engaged in unfair methods of competition, unlawful conditioning of payments, unreasonably restrained trade, and have an unlawful monopoly (the “FTC lawsuit”). In December 2022, attorneys general in Tennessee and Washington joined the FTC lawsuit and the Arkansas state attorney general filed a separate lawsuit against Corteva and another competitor based on the allegations set forth in the FTC lawsuit. Several proposed private class action lawsuits were also filed in federal court alleging anticompetitive conduct based on the allegations set forth in the FTC lawsuit. In February 2023, these private lawsuits were centralized into a multi-district litigation in the U.S. District Court for the Middle District of North Carolina. We believe any such lawsuits related to Corteva’s business practices are without merit. Litigation related to legacy EIDP businesses unrelated to Corteva’s current businesses For purposes of this report, the term PFOA means collectively perfluorooctanoic acid and its salts, including the ammonium salt and does not distinguish between the two forms, and PFAS, including PFOA, PFOS (perfluorooctanesulfonic acid), GenX and other perfluorinated chemicals and compounds ("PFCs"). EIDP is a party to various legal proceedings relating to the use of PFOA by its former Performance Chemicals segment for which potential liabilities would be subject to the cost sharing arrangement under the MOU as long as it remains effective. Leach Settlement and Ohio MDL Settlement EIDP has residual liabilities under its 2004 settlement of a West Virginia state court class action, Leach v. EIDP, which alleged that PFOA from EIDP’s former Washington Works facility had contaminated area drinking water supplies and affected the health of area residents. The settlement class has about 80,000 members. In addition to relief that was provided to class members years ago, the settlement requires EIDP to continue providing PFOA water treatment to six area water districts and private well users and to fund, through an escrow account, up to $235 million for a medical monitoring program for eligible class members. As of March 31, 2023, approximately $2 million had been disbursed from the account since its establishment in 2012 and the remaining balance is approximately $1 million. The Leach settlement permits class members to pursue personal injury claims for six health conditions (and no others) that an expert panel appointed under the settlement reported in 2012 had a “probable link” (as defined in the settlement) with PFOA: pregnancy-induced hypertension, including preeclampsia; kidney cancer; testicular cancer; thyroid disease; ulcerative colitis; and diagnosed high cholesterol. After the panel reported its findings, approximately 3,550 personal injury lawsuits were filed in federal and state courts in Ohio and West Virginia and consolidated in multi-district litigation in the U.S. District Court for the Southern District of Ohio (“Ohio MDL”). The Ohio MDL was settled in early 2017 for approximately $670 million in cash, with Chemours and EIDP (without indemnification from Chemours) each paying half. Post-MDL Settlement PFOA Personal Injury Claims The 2017 Ohio MDL settlement did not resolve claims of plaintiffs who did not have claims in the Ohio MDL or whose claims are based on diseases first diagnosed after February 11, 2017. The first was a consolidated trial of two cases; the first, a kidney cancer case, which resulted in a hung jury, while the second, Travis and Julie Abbott v. E.I du Pont de Nemours and Company (the “Abbott Case”), a testicular cancer case, resulted in a jury verdict of $40 million in compensatory damages and $10 million for loss of consortium, plus interest. The loss of consortium award was subsequently reduced to $250,000 in accordance with state law limitations. Following entry of the judgment by the court, EIDP filed post-trial motions to reduce the verdict, and to appeal the verdict on the basis of procedural and substantive legal errors made by the trial court. In December 2022, the Sixth Circuit federal court ruled against the company's appeal of the jury verdict. EIDP's motion for en banc review was denied in February 2023. Defense costs and future liabilities that may arise from these cases are subject to the terms and conditions of the MOU and the Corteva Separation Agreement. As of March 31, 2023, an accrual was established for this matter. In January 2021, Chemours, DuPont and Corteva agreed to settle the remaining approximately 95 matters, as well as unfiled matters, remaining in the Ohio MDL, with the exception of the Abbott case, for $83 million, with Chemours contributing $29 million to the settlement, and DuPont and Corteva contributing $27 million each. The company paid $27 million during the year ended December 31, 2021. As agreed to in the settlement, the plaintiffs' counsel filed a motion to dissolve the MDL. In December 2022, the motion to dissolve the MDL was denied. Other PFOA Matters EIDP is a party to other PFOA lawsuits involving claims for property damage, medical monitoring and personal injury. Defense costs and any future liabilities that may arise out of these lawsuits are subject to the MOU and the cost sharing arrangement disclosed above. Under the MOU, fraudulent conveyance claims associated with these matters are not qualified expenses, unless Corteva, Inc. and EIDP would prevail on the merits of these claims. EIDP did not make firefighting foams, PFOS, or PFOS products. While EIDP made surfactants and intermediaries that some manufacturers used in making foams, which may have contained PFOA as an unintended byproduct or an impurity, EIDP’s products were not formulated with PFOA, nor was PFOA an ingredient of these products. EIDP has never made or sold PFOA as a commercial product. In March 2023, the U.S. Environmental Protection Agency ("EPA") published proposed rules establishing a maximum contaminate level of four parts per trillion for PFOA in drinking water. If such rules are adopted, a legal mandate with respect to acceptable PFOA levels in drinking water would be established. Aqueous Firefighting Foams . Approximately 3,900 cases have been filed against 3M and other defendants, including EIDP and Chemours, and some including Corteva and DuPont, alleging PFOS or PFOA environmental contamination and/or personal injury from the use of aqueous firefighting foams. The majority of these cases have been transferred to a multi-district litigation proceeding in federal district court in South Carolina. Approximately 3,500 of these cases were filed on behalf of firefighters who allege personal injuries (primarily kidney and testicular cancer) as a result of exposure to aqueous firefighting foams. Approximately 300 of these cases were filed by water utility or municipal water districts. Most of these recent cases assert claims that the EIDP and Chemours separation constituted a fraudulent conveyance. The Stuart, Florida water district "bellwether" trial is scheduled for June 2023. The court has encouraged all parties to discuss resolution of the water utility and water district category of cases, and has appointed a mediator to facilitate discussions between the parties. Consistent with the Court's instruction and under the mutual obligations of the MOU, Corteva, EIDP, DuPont and Chemours have engaged with the plaintiff's counsel on the resolution of these cases. New Jersey . In late March of 2019, the New Jersey State Attorney General filed four lawsuits against EIDP, Chemours, and others alleging that operations at and discharges from former EIDP sites in New Jersey (Chambers Works, Pompton Lakes, Parlin and Repauno) damaged the State’s natural resources. Two of these lawsuits (those involving the Chambers Works and Parlin sites) allege contamination from PFAS. The Ridgewood Water District in New Jersey filed suit in the first quarter 2019 against EIDP, Chemours, and others alleging losses related to the investigation, remediation and monitoring of polyfluorinated surfactants, including PFOA, in water supplies. DuPont and Corteva were subsequently added as defendants to these lawsuits. These lawsuits include claims under the New Jersey Industrial Site Recovery Act ("ISRA") and for fraudulent conveyance. Beginning in April 2023, the lawsuits have been stayed subject to a court appointed mediation. EIDP and Chemours are also defendants in two lawsuits by a private water utility provider in New Jersey and New York alleging damages from PFAS releases into the environment, that impacted water sources that the utilities use to provide water, as well as products liability, negligence, nuisance, and trespass claims. The court dismissed the New York plaintiff's trespass claims and has limited plaintiffs’ nuisance claims to abatement damages. Ohio . EIDP is a defendant in three lawsuits, including an action by the State of Ohio based on alleged damage to natural resources, and an action by the City of Dayton claiming losses related to the investigation, remediation and monitoring of PFAS in water supplies. The trial with respect to the natural resources lawsuit is scheduled for February 2024. The third lawsuit, a putative nationwide class action ("the Hardwick Class Action") brought on behalf of anyone who has detectable levels of PFAS in their blood serum seeks declaratory and injunctive relief, including the establishment of a “PFAS Science Panel.” In March 2022, the trial court certified a class covering anyone subject to Ohio laws having minimal levels of PFOA plus at least one other PFAS in their blood. The trial court requested further briefing on whether the class should be extended to include other states that recognize analogous claims for relief. Because EIDP and the other defendants were granted permission by the court to appeal the class certification decision, further briefing on the extension of the class for the trial court has been paused subject to the outcome of the appeal. New York . EIDP is a defendant in about 45 lawsuits, including a putative class action (the "Baker Class Action"), brought by persons who live in and around Hoosick Falls, New York. These lawsuits assert claims for medical monitoring, property damage and personal injury based on alleged PFOA releases from manufacturing facilities owned and operated by co-defendants in Hoosick Falls. The lawsuits allege that EIDP and others supplied materials used at these facilities resulting in PFOA air and water contamination. A court approved settlement was reached between the plaintiffs and the other co-defendants regarding the Baker Class Action case. In September 2022, the class certification of the Baker Class Action was granted, with the court certifying three separate classes consisting of a private well property damage class, a medical monitoring class and a nuisance class. EIDP will challenge the certification, and continue to defend itself on the merits of the case, while seeking an out of court resolution. A portion of the personal injury lawsuits filed by Hoosick Falls residents are in the process of being mediated. EIDP is also one of more than ten defendants in a lawsuit brought by the Town of East Hampton, New York alleging PFOA and PFOS contamination of the town’s well water. Additionally, EIDP along with Chemours and others, have been named defendants in complaints filed by 11 water districts in Nassau County, New York alleging that the drinking water they provide to customers is contaminated with PFAS and seeking reimbursement for clean-up costs. The water district complaints also include allegations of fraudulent transfer. Other Natural Resource Damage Cases. In the states of Alabama, Alaska, California, Florida, Illinois, Kentucky, Maine, Massachusetts, Michigan, Mississippi, New Hampshire, North Carolina, Pennsylvania, South Dakota, Vermont and Wisconsin, along with Guam and the Marina Islands, filed lawsuits against EIDP, Chemours, and others, claiming, among other things, PFC (including PFOA) contamination of groundwater and drinking water. The complaints seek reimbursement for past and future costs to investigate and remediate the alleged contamination and compensation for the loss of value and use of the state’s natural resources. On July 13, 2021, Chemours, DuPont, EIDP and Corteva entered into a settlement agreement with the State of Delaware reflecting the companies’ and the State’s agreement to settle and fully resolve claims alleged against the companies regarding their historical Delaware operations, manufacturing, use and disposal of all chemical compounds, including PFAS. Under the settlement, if the companies, individually or jointly, within 8 years of the settlement, enter into a proportionally similar agreement to settle or resolve claims of another state for PFAS-related natural resource damages, for an amount greater than $50 million, the companies shall make a supplemental payment directly to the Natural Resources and Sustainability Trust (the "NRS Trust") in an amount equal to such other states’ recovery in excess of $50 million ("Supplemental Payment"). Supplemental Payment(s), if any, will not exceed $25 million in the aggregate. All amounts paid by the companies under the settlement are subject to the MOU and the Corteva Separation Agreement. Under the settlement, if the state sues other parties and those parties seek contribution from the companies, the companies will have protection from contribution up to the amounts previously paid under the settlement agreement. The companies will also receive a credit up to the amount of the payment if the state seeks natural resource damage claims against the companies outside the scope of the settlement’s release of claims. Netherlands . In April 2021, four municipalities in the Netherlands filed complaints alleging contamination of land and groundwater resulting from the emission of PFOA and GenX by Corteva, DuPont and Chemours. The municipalities seek to recover costs incurred due to the alleged emissions, including damages for investigation costs, construction project delays, depreciation of land, soil remediation, liabilities to contractors, and attorneys’ fees. A hearing on the merits occurred in March 2023, and a ruling is expected by September 2023. Carpet Mill Cases. The city of Rome, GA alleges defendants, including EIDP, Chemours, other chemical suppliers and large carpet mills, discharged PFAS in their industrial wastewater, and that this wastewater after treatment, resulted in PFAS contamination of drinking water supplies. The city of Rome seeks damages for the cost of the installation of a water treatment system capable of removing PFCs from the water, injunctive relief requiring the defendants to clean up the contamination in the river ways, and punitive damages. Additionally, the city of Rome has sent a demand to EIDP asserting damages for the construction of a new utilities wastewater treatment system and upgrades to the city's water treatment system, along with future monitoring costs. While mediation continues, a trial is currently scheduled for June 5, 2023. Fayetteville Works Facility, North Carolina Prior to the separation of Chemours, EIDP introduced GenX as a polymerization processing aid and a replacement for PFOA at the Fayetteville Works facility in Bladen County, North Carolina. The facility is now owned and operate

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	STOCKHOLDERS' EQUITY Share Buyback Plan On September 13, 2022, Corteva, Inc. announced that its Board of Directors authorized a $2 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2022 Share Buyback Plan"). The timing, price and volume of purchases in connection with the 2022 Share Buyback Plan will be based on market conditions, relevant securities laws and other factors. On August 5, 2021, Corteva, Inc. announced that its Board of Directors authorized a $1.5 billion share repurchase program to purchase Corteva, Inc.'s common stock, par value $0.01 per share, without an expiration date ("2021 Share Buyback Plan"). In connection with the 2021 Share Buyback Plan, the company repurchased and retired 4,098,000 shares and 4,585,000 shares in the open market for a total cost of $250 million and $235 million during the three months ended March 31, 2023 and 2022, respectively. Repurchases under the 2021 Share Buyback Plan are now complete with the first quarter 2023 activity noted above. Shares repurchased pursuant to Corteva's share buyback plans are immediately retired upon repurchase. Repurchased common stock is reflected as a reduction of stockholders' equity. The company's accounting policy related to its share repurchases is to reduce its common stock based on the par value of the shares and to reduce its retained earnings for the excess of the repurchase price over the par value. When Corteva has an accumulated deficit balance, the excess over the par value is applied to APIC. When Corteva has retained earnings, the excess is charged entirely to retained earnings. Noncontrolling Interest Corteva, Inc. owns 100 percent of the outstanding common shares of EIDP. However, EIDP has preferred stock outstanding to third parties which is accounted for as a non-controlling interest in Corteva's interim Consolidated Balance Sheets. Each share of EIDP Preferred Stock - $4.50 Series and EIDP Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EIDP and was unaffected by the Corteva Distribution. Below is a summary of the EIDP Preferred Stock at March 31, 2023, December 31, 2022, and March 31, 2022, which is classified as noncontrolling interests in Corteva's interim Consolidated Balance Sheets. Shares in thousands Number of Shares Authorized 23,000 $4.50 Series, callable at $120 1,673 $3.50 Series, callable at $102 700 Other Comprehensive Income (Loss) The changes and after-tax balances of components comprising accumulated other comprehensive income (loss) are summarized below: (In millions) Cumulative Translation Adjustment 1 Derivative Instruments Pension Benefit Plans Other Benefit Plans Total 2022 Balance January 1, 2022 $ (2,543) $ 72 $ (396) $ (31) $ (2,898) Other comprehensive income (loss) before reclassifications 91 (13) 8 3 89 Amounts reclassified from accumulated other comprehensive income (loss) — (12) — — (12) Net other comprehensive income (loss) 91 (25) 8 3 77 Balance March 31, 2022 $ (2,452) $ 47 $ (388) $ (28) $ (2,821) 2023 Balance January 1, 2023 $ (2,883) $ 80 $ (163) $ 160 $ (2,806) Other comprehensive income (loss) before reclassifications 134 (51) 3 — 86 Amounts reclassified from accumulated other comprehensive income (loss) — (16) (1) (2) (19) Net other comprehensive income (loss) 134 (67) 2 (2) 67 Balance March 31, 2023 $ (2,749) $ 13 $ (161) $ 158 $ (2,739) 1. The cumulative translation adjustment gain for the three months ended March 31, 2023 was primarily driven by the weakening of the USD against the European Euro ("EUR"), Brazilian Real ("BRL"), Mexican Peso ("MXN"), and Swiss Franc ("CHF"). The cumulative translation adjustment gain for the three months ended March 31, 2022 was primarily driven by the weakening of the USD against the Brazilian Real ("BRL") partially offset by the strengthening of the USD against the European Euro ("EUR") and Swiss Franc ("CHF"). The tax (expense) benefit on the net activity related to each component of other comprehensive income (loss) was as follows: (In millions) Three Months Ended 2023 2022 Derivative instruments $ 27 $ (1) Pension benefit plans - net — (2) Other benefit plans - net — 3 (Provision for) benefit from income taxes related to other comprehensive income (loss) items $ 27 $ — A summary of the reclassifications out of accumulated other comprehensive income (loss) is provided as follows: (In millions) Three Months Ended 2023 2022 Derivative Instruments 1 : $ (21) $ (15) Tax (benefit) expense 2 5 3 After-tax $ (16) $ (12) Amortization of pension benefit plans: Prior service (benefit) cost 3,4 $ (1) $ (1) Actuarial (gains) losses 3,4 — 1 Total before tax $ (1) $ — Tax (benefit) expense 2 — — After-tax $ (1) $ — Amortization of other benefit plans: Actuarial (gains) loss 3,4 (2) — Total before tax $ (2) $ — Tax (benefit) expense 2 — — After-tax $ (2) $ — Total reclassifications for the period, after-tax $ (19) $ (12) 1. Reflected in cost of goods sold in the interim Consolidated Statements of Operations. 2. Reflected in provision for (benefit from) income taxes from continuing operations in the interim Consolidated Statements of Operations. 3. These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, for additional information.

Pension Plans and Other Post Em

Pension Plans and Other Post Employment Benefit Plans	3 Months Ended
	Mar. 31, 2023
Retirement Benefits [Abstract]
Pension and other Post Employment Benefits	PENSION PLANS AND OTHER POST EMPLOYMENT BENEFITS The following sets forth the components of the company's net periodic benefit (credit) cost for defined benefit pension plans and other post employment benefits: Three Months Ended (In millions) 2023 2022 Defined Benefit Pension Plans: Service cost $ 5 $ 4 Interest cost 174 108 Expected return on plan assets (152) (190) Amortization of unrecognized (gain) loss — 1 Amortization of prior service (benefit) cost (1) (1) Net periodic benefit (credit) cost $ 26 $ (78) Other Post Employment Benefits: Interest cost $ 12 $ 7 Amortization of unrecognized (gain) loss (2) — Net periodic benefit (credit) cost $ 10 $ 7

Financial Instruments

Financial Instruments	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments Disclosure [Text Block]	FINANCIAL INSTRUMENTS At March 31, 2023, December 31, 2022 and March 31, 2022, the company had $780 million, $2,296 million and $1,414 million, respectively, of held-to-maturity securities (primarily time deposits and money market funds) classified as cash equivalents in the interim Consolidated Balance Sheets, as these securities had maturities of three months or less at the time of purchase; $85 million, $124 million and $290 million at March 31, 2023, December 31, 2022 and March 31, 2022, respectively, of held-to-maturity securities (primarily time deposits and foreign government bonds) classified as marketable securities in the interim Consolidated Balance Sheets, as these securities had maturities of more than three months to less than one year at the time of purchase; and $27 million, $27 million and $53 million at March 31, 2023, December 31, 2022 and March 31, 2022, respectively, of held-to-maturity securities (primarily foreign government bonds) classified as marketable securities and included in other assets in the interim Consolidated Balance Sheets, as these securities had maturities more than one year at the time of purchase. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. The company’s held-to-maturity securities relating to investments in foreign government bonds at March 31, 2023 are discussed further in the “Debt Securities” section. Derivative Instruments Objectives and Strategies for Holding Derivative Instruments In the ordinary course of business, the company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and commodity price risks. The company has established a variety of derivative programs to be utilized for financial risk management. These programs reflect varying levels of exposure coverage and time horizons based on an assessment of risk. Derivative programs have procedures and controls and are approved by the Corporate Financial Risk Management Committee, consistent with the company's financial risk management policies and guidelines. Derivative instruments used are forwards, options, futures and swaps. The company has not designated any non-derivatives as hedging instruments. The company's financial risk management procedures also address counterparty credit approval, limits and routine exposure monitoring and reporting. The counterparties to these contractual arrangements are major financial institutions and major commodity exchanges, and multinational grain exporters. The company is exposed to credit loss in the event of nonperformance by these counterparties. The company utilizes collateral support annex agreements with certain counterparties to limit its exposure to credit losses. The company anticipates performance by counterparties to these contracts and therefore no material loss is expected. Market and counterparty credit risks associated with these instruments are regularly reported to management. The notional amounts of the company's derivative instruments were as follows: Notional Amounts (In millions) March 31, 2023 December 31, 2022 March 31, 2022 Derivatives designated as hedging instruments: Foreign currency contracts $ 470 $ 953 $ 1,043 Commodity contracts $ 786 $ 1,167 $ 531 Derivatives not designated as hedging instruments: Foreign currency contracts $ 2,320 $ 430 $ 1,106 Commodity contracts $ 108 $ 9 $ 81 Foreign Currency Risk The company's objective in managing exposure to foreign currency fluctuations is to reduce earnings and cash flow volatility associated with foreign currency rate changes. Prior to the first quarter of 2023, the company mitigated the exposure of certain investments in foreign subsidiaries against changes in the Euro/USD exchange rate. Accordingly, the company enters into various contracts that change in value as foreign exchange rates change to protect the value of its existing foreign currency-denominated assets, liabilities, commitments, investments and cash flows. The company uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The primary business objective of this hedging program is to maintain an approximately balanced position in foreign currencies so that exchange gains and losses resulting from exchange rate changes, after related tax effects, are minimized. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to certain forecasted transactions as well as the translation of foreign currency-denominated earnings. The company also uses commodity contracts to offset risks associated with foreign currency devaluation in certain countries. Commodity Price Risk Commodity price risk management programs serve to reduce exposure to price fluctuations on purchases of inventory such as corn and soybeans. The company enters into over-the-counter and exchange-traded derivative commodity instruments to hedge the commodity price risk associated with agricultural commodity exposures. Derivatives Designated as Cash Flow Hedges Commodity Contracts The company enters into over-the-counter and exchange-traded derivative commodity instruments, including options, forwards, futures and swaps, to hedge the commodity price risk associated with agriculture commodity exposures. While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is probable of not occurring. The following table summarizes the after-tax effect of commodity contract cash flow hedges on accumulated other comprehensive income (loss): Three Months Ended (In millions) 2023 2022 Beginning balance $ 55 $ 47 Additions and revaluations of derivatives designated as cash flow hedges (41) 63 Clearance of hedge results to earnings (15) (14) Ending balance $ (1) $ 96 At March 31, 2023, an after-tax net loss of $6 million is expected to be reclassified from accumulated other comprehensive income (loss) into earnings over the next twelve months. Foreign Currency Contracts The company enters into forward contracts to hedge the foreign currency risk associated with forecasted transactions within certain foreign subsidiaries. While each risk management program has a different time maturity period, most programs currently do not extend beyond the next two years. Cash flow hedge results are reclassified into earnings during the same period in which the related exposure impacts earnings. Reclassifications are made sooner if it appears that a forecasted transaction is probable of not occurring. The following table summarizes the after-tax effect of foreign currency cash flow hedges on accumulated other comprehensive income (loss): Three Months Ended (In millions) 2023 2022 Beginning balance $ 10 $ 32 Additions and revaluations of derivatives designated as cash flow hedges (10) (82) Clearance of hedge results to earnings (1) 2 Ending balance $ (1) $ (48) At March 31, 2023, an after-tax net loss of $1 million is expected to be reclassified from accumulated other comprehensive income (loss) into earnings over the next twelve months. Derivatives Designated as Net Investment Hedges Foreign Currency Contracts The company had designated €450 million of forward contracts to exchange EUR as net investment hedges. The purpose of these forward contracts was to mitigate foreign exchange exposure related to a portion of the company’s Euro net investments in certain foreign subsidiaries against changes in Euro/USD exchange rates. These hedges expired and were settled in March 2023. Prior to maturity, the company had elected to apply the spot method in testing for effectiveness of the hedging relationship. Derivatives not Designated in Hedging Relationships Foreign Currency Contracts The company uses foreign exchange contracts to reduce its net exposure, by currency, related to foreign currency-denominated monetary assets and liabilities of its operations so that exchange gains and losses resulting from exchange rate changes are minimized. The netting of such exposures precludes the use of hedge accounting; however, the required revaluation of the forward contracts and the associated foreign currency-denominated monetary assets and liabilities intends to achieve a minimal earnings impact, after taxes. The company also uses foreign currency exchange contracts to offset a portion of the company’s exposure to the translation of certain foreign currency-denominated earnings so that gains and losses on the contracts offset changes in the USD value of the related foreign currency-denominated earnings over the relevant aggregate period. Commodity Contracts The company utilizes options, futures and swaps that are not designated as hedging instruments to reduce exposure to commodity price fluctuations on purchases of inventory such as corn and soybeans. The company uses forward agreements, with durations less than one year, to buy and sell USD priced commodities in order to reduce its exposure to currency devaluation for a portion of its local currency cash balances. Counterparties to the forward sales agreements are multinational grain exporters and subject to the company’s financial risk management procedures. Fair Value of Derivative Instruments Asset and liability derivatives subject to an enforceable master netting arrangement with the same counterparty are presented on a net basis in the interim Consolidated Balance Sheets. The presentation of the company's derivative assets and liabilities is as follows: March 31, 2023 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the interim Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Commodity contracts Other current assets $ 2 $ — $ 2 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 41 (35) 6 Total asset derivatives $ 43 $ (35) $ 8 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 21 $ — $ 21 Commodity contracts Accrued and other current liabilities 10 — 10 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 66 (35) 31 Commodity contracts Accrued and other current liabilities 5 — 5 Total liability derivatives $ 102 $ (35) $ 67 December 31, 2022 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Other current assets $ 41 $ — $ 41 Commodities Contracts Other current assets 4 — 4 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 51 (40) 11 Total asset derivatives $ 96 $ (40) $ 56 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 9 $ — $ 9 Commodity contracts Accrued and other current liabilities 3 — 3 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 58 (40) 18 Total liability derivatives $ 70 $ (40) $ 30 March 31, 2022 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the interim Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Other current assets $ 16 $ — $ 16 Commodity Contracts Other current assets 5 — 5 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 21 (28) (7) Commodity contracts Other current assets 3 — 3 Total asset derivatives $ 45 $ (28) $ 17 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 80 $ — $ 80 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 114 (28) 86 Commodity contracts Accrued and other current liabilities 3 — 3 Total liability derivatives $ 197 $ (28) $ 169 1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. Effect of Derivative Instruments Amount of Gain (Loss) Recognized in OCI - Pre-Tax 1 Three Months Ended March 31, (In millions) 2023 2022 Derivatives designated as hedging instruments: Net investment hedges: Foreign currency contracts $ — $ 7 Cash flow hedges: Foreign currency contracts (15) (102) Commodity contracts (58) 86 Total derivatives designated as hedging instruments $ (73) $ (9) 1. OCI is defined as other comprehensive income (loss). Amount of Gain (Loss) Recognized in Income - Pre-Tax 1 Three Months Ended March 31, (In millions) 2023 2022 Derivatives designated as hedging instruments: Cash flow hedges: Foreign currency contracts 2 $ 2 $ (3) Commodity contracts 2 19 18 Total derivatives designated as hedging instruments $ 21 $ 15 Derivatives not designated as hedging instruments: Foreign currency contracts 3 $ (3) $ (53) Foreign currency contracts 2 (12) (36) Commodity contracts 2 (1) (22) Commodity contracts 3 (3) — Total derivatives not designated as hedging instruments (19) (111) Total derivatives $ 2 $ (96) 1. For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period. 2. Recorded in cost of goods sold in the interim Consolidated Statements of Operations. 3. Recognized in other income (expense). Note that net loss from foreign currency contracts was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, to the interim Consolidated Financial Statements, for additional information. Debt Securities The company’s debt securities include foreign government bonds classified as held-to-maturity securities at March 31, 2023, December 31, 2022 and March 31, 2022. The company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value, and are held by certain foreign subsidiaries in which the USD is the functional currency. The company's investments in debt securities at March 31, 2023 with a contractual maturity within one year and between one to five years was $83 million and $27 million, respectively.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	FAIR VALUE MEASUREMENTS The following tables summarize the basis used to measure certain assets and liabilities at fair value on a recurring basis: March 31, 2023 December 31, 2022 March 31, 2022 (In millions) Level 2 2 Level 2 2 Level 1 1 Level 2 2 Assets at fair value: Marketable securities $ 85 $ 124 $ — $ 290 Derivatives relating to: 3 Foreign currency 41 92 — 37 Commodity contracts 2 4 — 8 Equity Securities 4 — — 29 — Total assets at fair value $ 128 $ 220 $ 29 $ 335 Liabilities at fair value: Derivatives relating to: 3 Foreign currency 87 67 — 194 Commodity contracts 15 3 — 3 Total liabilities at fair value $ 102 $ 70 $ — $ 197 1. Reflects quoted prices in active markets for identical items. 2. Reflects significant other observable inputs. 3. See Note 16 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets. 4. The company's equity securities are included in other assets in the interim Consolidated Balance Sheets.

Segment Reporting (Notes)

Segment Reporting (Notes)	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	SEGMENT INFORMATION Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Non-operating benefits (costs) consists of non-operating pension and other post-employment benefit (OPEB) credits (costs), tax indemnification adjustments and environmental remediation and legal costs associated with legacy EIDP businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. As of and for the Three Months Ended March 31, (In millions) Seed Crop Protection Total 2023 Net sales $ 2,695 $ 2,189 $ 4,884 Segment operating EBITDA $ 652 $ 603 $ 1,255 Segment assets 1 $ 23,966 $ 17,584 $ 41,550 2022 Net sales $ 2,524 $ 2,077 $ 4,601 Segment operating EBITDA $ 569 $ 491 $ 1,060 Segment assets 1 $ 24,146 $ 14,144 $ 38,290 1. Segment assets at December 31, 2022 were $22,952 million and $14,097 million for Seed and Crop Protection, respectively. Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions) Three Months Ended 2023 2022 Income (loss) from continuing operations after income taxes $ 607 $ 577 Provision for (benefit from) income taxes on continuing operations 169 121 Income (loss) from continuing operations before income taxes 776 698 Depreciation and amortization 287 307 Interest income (40) (15) Interest expense 31 9 Exchange (gains) losses 36 47 Non-operating (benefits) costs 43 (65) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges 15 36 Significant items (benefit) charge 83 22 Corporate expenses 24 21 Segment operating EBITDA $ 1,255 $ 1,060 Segment assets to total assets (in millions) March 31, 2023 December 31, 2022 March 31, 2022 Total segment assets $ 41,550 $ 37,049 $ 38,290 Corporate assets 3,950 5,569 4,343 Total assets $ 45,500 $ 42,618 $ 42,633 Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA The three months ended March 31, 2023 and 2022, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA: (In millions) Seed Crop Protection Corporate Total For the Three Months Ended March 31, 2023 Restructuring and asset related charges - net 1 $ (21) $ (6) $ (6) $ (33) Estimated settlement expense 2 — (49) — (49) Inventory write-offs 3 (4) — — (4) Gain (loss) on sale of assets and equity investments 3 — 3 — 3 Seed sale associated with Russia Exit 3,4 19 — — 19 Acquisition-related costs 5 — (19) — (19) Total $ (6) $ (71) $ (6) $ (83) (In millions) Seed Crop Protection Corporate Total For the Three Months Ended March 31, 2022 Restructuring and asset related charges - net 1 $ (5) $ 2 $ (2) $ (5) Estimated settlement expense 2 — (17) — (17) Total $ (5) $ (15) $ (2) $ (22) 1. Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information. 2. Consists of estimated Lorsban® related charges. 3. Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. 4. Includes a benefit of $19 million relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the company was contractually required to purchase. It consists of $41 million of net sales and $22 million of cost of goods sold. 5. Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up. See Note 3 - Business Combinations, to the interim Consolidated Financial Statements, for additional information.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTS In May 2023, the company entered into a committed receivable repurchase facility of up to $500 million (the "2023 Repurchase Facility"), which expires in December 2023. Under the 2023 Repurchase Facility, Corteva may sell a portfolio of available and eligible outstanding customer notes receivables to participating institutions and simultaneously agree to repurchase at a future date. The 2023 Repurchase Facility is considered a secured borrowing with the customer notes receivables inclusive of those that are sold and repurchased, equal to 105 percent of the outstanding amounts borrowed utilized as collateral. Borrowings under the 2023 Repurchase Facility have an interest rate equal to the Adjusted Term Secured Overnight Financing Rate ("SOFR"), which is Term SOFR plus 0.10 percent, plus the margin.

EID - Basis of Presentation (No

EID - Basis of Presentation (Notes)	3 Months Ended
	Mar. 31, 2023
EID [Member]
Entity Information [Line Items]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	BASIS OF PRESENTATION Corteva, Inc. owns 100% of the outstanding common stock of EIDP. EIDP is a subsidiary of Corteva, Inc. and continues to be a reporting company, subject to the requirements of the Exchange Act. The primary differences between Corteva, Inc. and EIDP are outlined below: • Preferred Stock - EIDP has preferred stock outstanding to third parties which is accounted for as a non-controlling interest at the Corteva, Inc. level. Each share of EIDP Preferred Stock - $4.50 Series and EIDP Preferred Stock - $3.50 Series issued and outstanding at the effective date of the Corteva Distribution remains issued and outstanding as to EIDP and was unaffected by the Corteva Distribution. • Related Party Loan - EIDP engaged in a series of debt redemptions during the second quarter of 2019 that were partially funded through an intercompany loan from Corteva, Inc. This was eliminated in consolidation at the Corteva, Inc. level but remains on EIDP's consolidated financial statements at the standalone level (including the associated interest). • Capital Structure - At March 31, 2023, Corteva, Inc.'s capital structure consists of 710,678,000 issued shares of common stock, par value $0.01 per share. The accompanying footnotes relate to EIDP only, and not to Corteva, Inc., and are presented to show differences between EIDP and Corteva, Inc. For the footnotes listed below, refer to the following Corteva, Inc. footnotes: • Note 1 - Summary of Significant Accounting Policies - refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements • Note 2 - Recent Accounting Guidance - refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements • Note 3 - Business Combinations - refer to page 9 of the Corteva, Inc. interim Consolidated Financial Statements • Note 4 - Revenue - refer to page 11 of the Corteva, Inc. interim Consolidated Financial Statements • Note 5 - Restructuring and Asset Related Charges - Net - refer to page 14 of the Corteva, Inc. interim Consolidated Financial Statements • Note 6 - Supplementary Information - refer to page 15 of the Corteva, Inc. interim Consolidated Financial Statements • Note 7 - Income Taxes - refer to page 17 of the Corteva, Inc. interim Consolidated Financial Statements • Note 8 - Earnings Per Share of Common Stock - Not applicable for EIDP • Note 9 - Accounts and Notes Receivable - Net - refer to page 19 of the Corteva, Inc. interim Consolidated Financial Statements • Note 10 - Inventories - refer to page 20 of the Corteva, Inc. interim Consolidated Financial Statements • Note 11 - Goodwill and Other Intangible Assets - refer to page 20 of the Corteva, Inc. interim Consolidated Financial Statements • Note 12 - Short-Term Borrowings, Long-Term Debt and Available Credit Facilities - refer to page 21 of the Corteva, Inc. interim Consolidated Financial Statements. In addition, EIDP has a related party loan payable to Corteva, Inc.; refer to EIDP Note 2 - Related Party Transactions, below • Note 13 - Commitments and Contingent Liabilities - refer to page 23 of the Corteva, Inc. interim Consolidated Financial Statements • Note 14 - Stockholders' Equity - refer to page 30 of the Corteva, Inc. interim Consolidated Financial Statements • Note 15 - Pension Plans and Other Post Employment Benefits - refer to page 32 of the Corteva, Inc. interim Consolidated Financial Statements • Note 16 - Financial Instruments - refer to page 33 of the Corteva, Inc. interim Consolidated Financial Statements • Note 17 - Fair Value Measurements - refer to page 38 of the Corteva, Inc. interim Consolidated Financial Statements • Note 18 - Segment Information - Differences exist between Corteva, Inc. and EIDP; refer to EIDP Note 3 - Segment Information, below • Note 19 - Subsequent Events - refer to page 40 of the Corteva, Inc. interim Consolidated Financial Statements

EID - Related Party Transaction

EID - Related Party Transactions (Notes)	3 Months Ended
	Mar. 31, 2023
EID [Member]
Related Party Transaction [Line Items]
Related Party Transactions Disclosure [Text Block]	RELATED PARTY TRANSACTIONS Transactions with Corteva In the second quarter of 2019, EIDP entered into a related party revolving loan from Corteva, Inc., with a maturity date in 2024. As of March 31, 2023, December 31, 2022, and March 31, 2022, the outstanding related party loan balance was $429 million, $789 million, and $1,825 million, respectively (which approximates fair value), with interest rates of 6.52%, 6.52%, and 1.67%, respectively, and is reflected as long-term debt - related party in EIDP's interim Consolidated Balance Sheets. Additionally, EIDP has incurred tax deductible interest expense of $13 million and $9 million for the three months ended March 31, 2023 and 2022, respectively, associated with the related party loan from Corteva, Inc. As of March 31, 2023, December 31, 2022, and March 31, 2022, EIDP had payables to Corteva, Inc., of $32 million, $31 million and $32 million included in accrued and other current liabilities, respectively, and $115 million, $115 million, and $116 million, included in other noncurrent obligations, respectively, in the interim Consolidated Balance Sheets related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements (refer to page 24 of the Corteva, Inc. interim Consolidated Financial Statements for further details of the Separation Agreements).

EID Segment FN (Notes)

EID Segment FN (Notes)	3 Months Ended
	Mar. 31, 2023
Segment Reporting Information [Line Items]
Segment Reporting Disclosure [Text Block]	SEGMENT INFORMATION Corteva’s reportable segments reflects the manner in which its chief operating decision maker ("CODM") allocates resources and assesses performance, which is at the operating segment level (seed and crop protection). For purposes of allocating resources to the segments and assessing segment performance, segment operating EBITDA is the primary measure used by Corteva’s CODM. The company defines segment operating EBITDA as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, corporate expenses, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Non-operating benefits (costs) consists of non-operating pension and other post-employment benefit (OPEB) credits (costs), tax indemnification adjustments and environmental remediation and legal costs associated with legacy EIDP businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as pre-tax income or expense. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the respective segment results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. As of and for the Three Months Ended March 31, (In millions) Seed Crop Protection Total 2023 Net sales $ 2,695 $ 2,189 $ 4,884 Segment operating EBITDA $ 652 $ 603 $ 1,255 Segment assets 1 $ 23,966 $ 17,584 $ 41,550 2022 Net sales $ 2,524 $ 2,077 $ 4,601 Segment operating EBITDA $ 569 $ 491 $ 1,060 Segment assets 1 $ 24,146 $ 14,144 $ 38,290 1. Segment assets at December 31, 2022 were $22,952 million and $14,097 million for Seed and Crop Protection, respectively. Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions) Three Months Ended 2023 2022 Income (loss) from continuing operations after income taxes $ 607 $ 577 Provision for (benefit from) income taxes on continuing operations 169 121 Income (loss) from continuing operations before income taxes 776 698 Depreciation and amortization 287 307 Interest income (40) (15) Interest expense 31 9 Exchange (gains) losses 36 47 Non-operating (benefits) costs 43 (65) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges 15 36 Significant items (benefit) charge 83 22 Corporate expenses 24 21 Segment operating EBITDA $ 1,255 $ 1,060 Segment assets to total assets (in millions) March 31, 2023 December 31, 2022 March 31, 2022 Total segment assets $ 41,550 $ 37,049 $ 38,290 Corporate assets 3,950 5,569 4,343 Total assets $ 45,500 $ 42,618 $ 42,633 Significant Pre-tax (Charges) Benefits Not Included in Segment Operating EBITDA The three months ended March 31, 2023 and 2022, respectively, included the following significant pre-tax (charges) benefits which are excluded from segment operating EBITDA: (In millions) Seed Crop Protection Corporate Total For the Three Months Ended March 31, 2023 Restructuring and asset related charges - net 1 $ (21) $ (6) $ (6) $ (33) Estimated settlement expense 2 — (49) — (49) Inventory write-offs 3 (4) — — (4) Gain (loss) on sale of assets and equity investments 3 — 3 — 3 Seed sale associated with Russia Exit 3,4 19 — — 19 Acquisition-related costs 5 — (19) — (19) Total $ (6) $ (71) $ (6) $ (83) (In millions) Seed Crop Protection Corporate Total For the Three Months Ended March 31, 2022 Restructuring and asset related charges - net 1 $ (5) $ 2 $ (2) $ (5) Estimated settlement expense 2 — (17) — (17) Total $ (5) $ (15) $ (2) $ (22) 1. Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information. 2. Consists of estimated Lorsban® related charges. 3. Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. 4. Includes a benefit of $19 million relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the company was contractually required to purchase. It consists of $41 million of net sales and $22 million of cost of goods sold. 5. Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up. See Note 3 - Business Combinations, to the interim Consolidated Financial Statements, for additional information.
EID [Member]
Segment Reporting Information [Line Items]
Segment Reporting Disclosure [Text Block]	SEGMENT INFORMATION There are no differences in reporting structure or segments between Corteva, Inc. and EIDP. In addition, there are no differences between Corteva, Inc. and EIDP segment net sales, segment operating EBITDA, segment assets, or significant items by segment; refer to page 38 of the Corteva, Inc. interim Consolidated Financial Statements for background information on the segments as well as further details regarding segment metrics. The tables below reconcile income (loss) from continuing operations after income taxes to segment operating EBITDA, as differences exist between Corteva, Inc. and EIDP. Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions) Three Months Ended 2023 2022 Income (loss) from continuing operations after income taxes $ 597 $ 570 Provision for (benefit from) income taxes on continuing operations 166 119 Income (loss) from continuing operations before income taxes 763 689 Depreciation and amortization 287 307 Interest income (40) (15) Interest expense 44 18 Exchange (gains) losses 36 47 Non-operating (benefits) costs 43 (65) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges 15 36 Significant items (benefit) charge 83 22 Corporate expenses 24 21 Segment operating EBITDA $ 1,255 $ 1,060

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited interim Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. Results for interim periods should not be considered indicative of results for a full year. These interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and Notes thereto contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2022, collectively referred to as the “2022 Annual Report.” The interim Consolidated Financial Statements include the accounts of the company and all of its subsidiaries in which a controlling interest is maintained. Since 2018, Argentina has been considered a hyper-inflationary economy under U.S. GAAP and therefore the U.S. Dollar (“USD”) is the functional currency for our related subsidiaries. Argentina contributes approximately 5 percent to both the company's annual net sales and segment operating EBITDA. We remeasure net monetary assets and translate our financial statements utilizing the official Argentine Peso (“Peso”) to USD exchange rate. The ability to draw down Peso cash balances is limited at this time due to government restrictions and market availability of U.S. Dollars. The devaluation of the Peso relative to the USD over the last several years has resulted in the recognition of exchange losses (refer to Note 6 – Supplementary Information, to the interim Consolidated Financial Statements and the company's 2022 Annual Report). As of March 31, 2023, a further 10 percent deterioration in the official Peso to USD exchange rate would reduce the USD value of our net monetary assets and negatively impact pre-tax earnings by approximately $10 million. We will continue to assess the implications to our operations and financial reporting.

Recent Accounting Guidance Rece

Recent Accounting Guidance Recent Accounting Guidance (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Recent Accounting Guidance	Recently Adopted Accounting GuidanceIn September 2022, the FASB issued ASU 2022-04, Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations. This ASU includes amendments that require a buyer in supplier finance programs to disclose key terms of the programs and related obligations, including a rollforward of such obligations. This guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the rollforward requirements, which are effective for fiscal years beginning after December 15, 2023, and early adoption is permitted. Retrospective application to all periods in which a balance sheet is presented is required, except for the rollforward requirement, which will be applied prospectively. The company adopted this guidance on January 1, 2023 which resulted in certain disclosures being added relating to supplier financing programs and related obligations. See Note 13 – Commitments and Contingent Liabilities, to the interim Consolidated Financial Statements, for additional information.

Revenue Revenue Recognition (Po

Revenue Revenue Recognition (Policies)	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue Recognition, Sales of Goods	Products Substantially all of Corteva's revenue is derived from product sales. Product sales consist of sales of Corteva's products to farmers, distributors, and manufacturers. Corteva considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year. However, the company has some long-term contracts which can span multiple years. Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time according to shipping terms. Payment terms are generally less than one year from invoicing. The company elected the practical expedient and does not adjust the promised amount of consideration for the effects of a significant financing component when the company expects it will be one year or less between when a customer obtains control of the company's product and when payment is due. When the company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to or at shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. In addition, the company elected the practical expedient to expense any costs to obtain contracts as incurred, as the amortization period for these costs would have been one year or less. The transaction price includes estimates of variable consideration, such as rights of return, rebates, and discounts, that are reductions in revenue. All estimates are based on the company's historical experience, anticipated performance, and the company's best judgment at the time the estimate is made. Estimates of variable consideration included in the transaction price primarily utilize the expected value method based on historical experience. These estimates are reassessed each reporting period and are included in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur upon resolution of uncertainty associated with the variable consideration. The majority of contracts have a single performance obligation satisfied at a point in time and the transaction price is stated in the contract, usually as quantity times price per unit. For contracts with multiple performance obligations, the company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.
Revenue Recognition, Licenses of Intellectual Property	Licenses of Intellectual Property Corteva enters into licensing arrangements with customers under which it licenses its intellectual property. Revenue from the majority of intellectual property licenses is derived from sales-based royalties. Revenue for licensing agreements that contain

Business Combinations and Ass_2

Business Combinations and Asset Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of Business Acquisitions, by Acquisition	(In millions) Stoller Symborg Assets Cash and cash equivalents $ 95 $ — Accounts and notes receivable 238 16 Inventories 86 10 Other current assets 26 1 Property, plant and equipment 51 3 Goodwill 381 138 Other intangible assets 655 298 Deferred income taxes 7 — Other assets 8 2 Total assets acquired $ 1,547 $ 468 Liabilities Short-term borrowings 59 — Accounts payable 25 12 Income taxes payable 2 — Accrued and other current liabilities 60 12 Long-term debt 3 — Deferred income tax liabilities 154 74 Other noncurrent obligations 20 — Total liabilities assumed $ 323 $ 98 Net assets acquired $ 1,224 $ 370
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	Intangible Assets Stoller Symborg (In millions) Fair Value Weighted-Average Amortization Period (Years) Fair Value Weighted-Average Amortization Period (Years) Intangible assets with finite lives: Customer-related $ 491 13 $ — — Developed technology 121 14 229 12 Trademarks/trade names 43 15 55 12 Total intangible assets with finite lives 655 13 284 12 Intangible assets with infinite lives: IPR&D — — 14 — Total intangible assets with infinite lives — — 14 — Total intangible assets $ 655 $ 298

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Contract Balances	Contract Balances March 31, 2023 December 31, 2022 March 31, 2022 (In millions) Accounts and notes receivable - trade 1 $ 7,334 $ 4,261 $ 6,029 Contract assets - current 2 $ 26 $ 26 $ 24 Contract assets - noncurrent 3 $ 63 $ 64 $ 58 Deferred revenue - current $ 2,712 $ 3,388 $ 2,435 Deferred revenue - noncurrent 4 $ 103 $ 107 $ 104 1. Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets. 2. Included in other current assets in the interim Consolidated Balance Sheets. 3. Included in other assets in the interim Consolidated Balance Sheets.
Major Product Line [Member]
Disaggregation of Revenue [Line Items]
Disaggregation of Revenue	Three Months Ended (In millions) 2023 2022 Corn $ 1,979 $ 1,930 Soybean 269 172 Other oilseeds 301 277 Other 146 145 Seed 2,695 2,524 Herbicides 1,242 1,205 Insecticides 409 418 Fungicides 359 304 Other 179 150 Crop Protection 2,189 2,077 Total $ 4,884 $ 4,601
Geography [Domain]
Disaggregation of Revenue [Line Items]
Disaggregation of Revenue	Seed Three Months Ended (In millions) 2023 2022 North America 1 $ 1,323 $ 1,184 EMEA 2 1,012 926 Latin America 259 323 Asia Pacific 101 91 Total $ 2,695 $ 2,524 Crop Protection Three Months Ended (In millions) 2023 2022 North America 1 $ 879 $ 821 EMEA 2 801 656 Latin America 293 327 Asia Pacific 216 273 Total $ 2,189 $ 2,077 1. Represents U.S. & Canada. 2. Europe, Middle East, and Africa ("EMEA").

Restructuring and Asset Relat_2

Restructuring and Asset Related Charges (Tables)	3 Months Ended
	Mar. 31, 2023
2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	Three Months Ended March 31, 2023 (In millions) Seed $ 6 Crop Protection 1 Corporate expenses 4 Total 1 $ 11 1. This amount excludes other pre-tax charges recorded during the three months ended March 31, 2023 impacting the Seed segment included in cost of goods sold and other income (expense) - net, in the company's interim Consolidated Statement of Operations, relating to inventory write-offs and the loss on the sale of the company's interest in an equity investment. The following table is a summary of charges incurred related to 2022 Restructuring Actions for the three months ended March 31, 2023: Three Months Ended March 31, 2023 (In millions) Severance and related benefit costs $ 4 Asset related charges 7 Contract termination charges 1 — Total restructuring and asset related charges - net 2 $ 11 1. Contract terminations includes early lease terminations. 2. This amount excludes other pre-tax charges recorded during the three months ended March 31, 2023 included in cost of goods sold and other income (expense) - net, in the company's interim Consolidated Statement of Operations, relating to inventory write-offs and the loss on the sale of the company's interest in an equity investment. A reconciliation of the December 31, 2022 to the March 31, 2023 liability balances related to the 2022 Restructuring Actions is summarized below: (in millions) Severance and Related Benefit Costs Asset Related Contract Termination 1 Total Balance at December 31, 2022 $ 71 $ — $ 12 $ 83 Charges to income (loss) from continuing operations 4 7 — 11 Payments (12) — (11) (23) Asset write-offs — (7) — (7) Balance at March 31, 2023 $ 63 $ — $ 1 $ 64 1. The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by the end of 2023.

Supplementary Information (Tabl

Supplementary Information (Tables)	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Other Nonoperating Income (Expense)	Other Income (Expense) - Net Three Months Ended (In millions) 2023 2022 Interest income $ 40 $ 15 Equity in earnings (losses) of affiliates - net 3 10 Net gain (loss) on sales of businesses and other assets (1) (3) Net exchange gains (losses) 1 (36) (47) Non-operating pension and other post employment benefit credit (costs) 2 (31) 75 Miscellaneous income (expenses) - net 3 (46) (33) Other income (expense) - net $ (71) $ 17 1. Includes net pre-tax exchange gains (losses) of $(21) million and $(15) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2023 and 2022, respectively. 2. Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)).
Foreign Currency Exchange Gain (Loss)	(In millions) Three Months Ended 2023 2022 Subsidiary Monetary Position Gain (Loss) Pre-tax exchange gain (loss) $ (30) $ 6 Local tax (expenses) benefits 9 (4) Net after-tax impact from subsidiary exchange gain (loss) $ (21) $ 2 Hedging Program Gain (Loss) Pre-tax exchange gain (loss) $ (6) $ (53) Tax (expenses) benefits 2 13 Net after-tax impact from hedging program exchange gain (loss) $ (4) $ (40) Total Exchange Gain (Loss) Pre-tax exchange gain (loss) $ (36) $ (47) Tax (expenses) benefits 11 9 Net after-tax exchange gain (loss) $ (25) $ (38)
Restrictions on Cash and Cash Equivalents	(In millions) March 31, 2023 December 31, 2022 March 31, 2022 Cash and cash equivalents $ 1,646 $ 3,191 $ 2,031 Restricted cash equivalents 422 427 354 Total cash, cash equivalents and restricted cash equivalents $ 2,068 $ 3,618 $ 2,385

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Net Income (Loss) for Earnings (Loss) Per Share Calculations - Basic and Diluted Three Months Ended (In millions) 2023 2022 Income (loss) from continuing operations after income taxes $ 607 $ 577 Net income (loss) attributable to continuing operations noncontrolling interests 4 3 Income (loss) from continuing operations available to Corteva common stockholders 603 574 (Loss) income from discontinued operations available to Corteva common stockholders (8) (10) Net income (loss) available to common stockholders $ 595 $ 564
Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]	Earnings (Loss) Per Share Calculations - Basic Three Months Ended (Dollars per share) 2023 2022 Earnings (loss) per share of common stock from continuing operations $ 0.85 $ 0.79 (Loss) earnings per share of common stock from discontinued operations (0.01) (0.01) Earnings (loss) per share of common stock $ 0.84 $ 0.78
Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]	Earnings (Loss) Per Share Calculations - Diluted Three Months Ended (Dollars per share) 2023 2022 Earnings (loss) per share of common stock from continuing operations $ 0.84 $ 0.79 (Loss) earnings per share of common stock from discontinued operations (0.01) (0.01) Earnings (loss) per share of common stock $ 0.83 $ 0.78
Share Count Information	Share Count Information Three Months Ended (Shares in millions) 2023 2022 Weighted-average common shares - basic 712.9 727.0 Plus dilutive effect of equity compensation plans 1 3.3 3.9 Weighted-average common shares - diluted 716.2 730.9 Potential shares of common stock excluded from EPS calculations 2 2.7 2.5 1. Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect. 2. These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Accounts and Notes Receivable_2

Accounts and Notes Receivable (Tables)	3 Months Ended
	Mar. 31, 2023
Accounts and Notes Receivable [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	(In millions) March 31, 2023 December 31, 2022 March 31, 2022 Accounts receivable – trade 1 $ 6,883 $ 4,168 $ 5,603 Notes receivable – trade 1,2 451 93 426 Other 3 1,344 1,440 1,246 Total accounts and notes receivable - net $ 8,678 $ 5,701 $ 7,275 1. Accounts receivable – trade and notes receivable - trade are net of allowances of $207 million, $194 million, and $232 million at March 31, 2023, December 31, 2022, and March 31, 2022, respectively. 2. Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of March 31, 2023, December 31, 2022, and March 31, 2022 there were no significant impairments related to current loan agreements. 3. Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 5 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $137 million, $148 million, and $124 million as of March 31, 2023, December 31, 2022, and March 31, 2022, respectively.
Accounts Receivable, Allowance for Credit Loss [Table Text Block]	(In millions) 2022 Balance at December 31, 2021 $ 210 Net provision for credit losses 5 Write-offs charged against allowance / other 17 Balance at March 31, 2022 $ 232 2023 Balance at December 31, 2022 $ 194 Net provision for credit losses 10 Write-offs charged against allowance / other 3 Balance at March 31, 2023 $ 207

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2023
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	(In millions) March 31, 2023 December 31, 2022 March 31, 2022 Finished products $ 3,650 $ 3,260 $ 2,691 Semi-finished products 2,023 2,689 1,635 Raw materials and supplies 912 862 660 Total inventories $ 6,585 $ 6,811 $ 4,986

Other Intangible Assets (Tables

Other Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Other Intangible Assets	(In millions) March 31, 2023 1 December 31, 2022 March 31, 2022 Gross Accumulated Net Gross Accumulated Net Gross Accumulated Net Intangible assets subject to amortization (Definite-lived): Germplasm $ 6,291 $ (890) $ 5,401 $ 6,291 $ (826) $ 5,465 $ 6,265 $ (634) $ 5,631 Customer-related 2,407 (617) 1,790 1,912 (585) 1,327 1,953 (515) 1,438 Developed technology 1,845 (868) 977 1,485 (830) 655 1,485 (716) 769 Trademarks/trade names 2,107 (271) 1,836 2,009 (251) 1,758 2,011 (192) 1,819 Favorable supply contracts 2 475 (420) 55 Other 3 395 (276) 119 395 (271) 124 405 (262) 143 Total other intangible assets with finite lives 13,045 (2,922) 10,123 12,092 (2,763) 9,329 12,594 (2,739) 9,855 Intangible assets not subject to amortization (Indefinite-lived): IPR&D 14 — 14 10 — 10 10 — 10 Total other intangible assets 14 — 14 10 — 10 10 — 10 Total $ 13,059 $ (2,922) $ 10,137 $ 12,102 $ (2,763) $ 9,339 $ 12,604 $ (2,739) $ 9,865 1. Includes the intangible assets acquired in connection with the Stoller and Symborg acquisitions, which were completed on March 1, 2023. See Note 3 – Business Combinations, to the interim Consolidated Financial Statements, for additional information. 2. Effective November 1, 2022, the favorable supply contracts expired and were fully amortized. 3. Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.
Schedule of Goodwill	(In millions) Crop Protection Seed Total Balance as of December 31, 2022 $ 4,618 $ 5,344 $ 9,962 Acquisitions 1 519 — 519 Currency translation adjustments 13 14 27 Balance as of March 31, 2023 $ 5,150 $ 5,358 $ 10,508 1. On March 1, 2023, the company completed the acquisitions of Stoller and Symborg, which are included in the crop protection segment. See Note 3 – Business Combinations, to the interim Consolidated Financial Statements, for additional information.

Short-Term Borrowings, Long-T_2

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Debt (Tables)	3 Months Ended
	Mar. 31, 2023
Debt Instrument [Line Items]
Schedule of Long-term Debt Instruments [Table Text Block]	Long-term debt (in millions) March 31, 2023 December 31, 2022 March 31, 2022 Amount Weighted Average Rate Amount Weighted Average Rate Amount Weighted Average Rate Promissory notes and debentures: Maturing in 2025 $ 500 1.70 % $ 500 1.70 % $ 500 1.70 % Maturing in 2030 500 2.30 % 500 2.30 % 500 2.30 % Other loans: Foreign currency loans, various rates and maturities 187 14.80 % 181 14.80 % 53 15.00 % Medium-term notes, varying maturities through 2041 107 4.62 % 107 4.27 % 107 0.35 % Finance lease obligations 3 2 3 Less: Unamortized debt discount and issuance costs 7 7 9 Less: Long-term debt due within one year 49 — — Total long-term debt $ 1,241 $ 1,283 $ 1,154
Schedule of Short-term Debt [Table Text Block]	Short-term borrowings and finance lease obligations (In millions) March 31, 2023 December 31, 2022 March 31, 2022 Commercial paper $ 2,680 $ — $ 984 364-Day Revolving Credit Facility 1,000 — — Other loans - various currencies 57 23 33 Long-term debt payable within one year 49 — — Finance lease obligations payable within one year 1 1 1 Total short-term borrowings and finance lease obligations $ 3,787 $ 24 $ 1,018
Schedule of Long-term Debt Instruments [Table Text Block]	Long-term debt (in millions) March 31, 2023 December 31, 2022 March 31, 2022 Amount Weighted Average Rate Amount Weighted Average Rate Amount Weighted Average Rate Promissory notes and debentures: Maturing in 2025 $ 500 1.70 % $ 500 1.70 % $ 500 1.70 % Maturing in 2030 500 2.30 % 500 2.30 % 500 2.30 % Other loans: Foreign currency loans, various rates and maturities 187 14.80 % 181 14.80 % 53 15.00 % Medium-term notes, varying maturities through 2041 107 4.62 % 107 4.27 % 107 0.35 % Finance lease obligations 3 2 3 Less: Unamortized debt discount and issuance costs 7 7 9 Less: Long-term debt due within one year 49 — — Total long-term debt $ 1,241 $ 1,283 $ 1,154
Schedule of Line of Credit Facilities	Committed and Available Credit Facilities at March 31, 2023 (in millions) Effective Date Committed Credit Credit Available Maturity Date Interest Revolving Credit Facility May 2022 $ 3,000 $ 3,000 May 2027 Floating Rate Revolving Credit Facility May 2022 2,000 2,000 May 2025 Floating Rate 364-day Revolving Credit Facility May 2022 1,000 — January 2024 Floating Rate Total Committed and Available Credit Facilities $ 6,000 $ 5,000

Commitments and Contingent Li_2

Commitments and Contingent Liabilities (Tables)	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Environmental Loss Contingencies by Site [Table Text Block]	As of March 31, 2023 (In millions) Indemnification Asset Accrual balance 3 Potential exposure above amount accrued 3 Environmental Remediation Stray Liabilities Chemours related obligations - subject to indemnity 1,2 $ 152 $ 152 $ 275 Other discontinued or divested businesses obligations 1 24 69 192 Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont 2 56 59 62 Environmental remediation liabilities not subject to indemnity — 113 63 Indemnification liabilities related to the MOU 4 25 126 30 Total $ 257 $ 519 $ 622 1. Represents liabilities that are subject to the $200 million threshold and sharing arrangements as discussed on page 24, under the header "Corteva Separation Agreement." 2. The company has recorded an indemnification asset related to these accruals, including $35 million related to the Superfund sites. 3. Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $59 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPA's October 2021 PFAS Strategic Roadmap (as applicable), except as disclosed on page 24 relating to Chemours' remediation activities at the Fayetteville Works Facility pursuant to the Consent Order with the NC DEQ. 4. Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page 23, under the header "Chemours / Performance Chemicals."

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Schedule of Noncontrolling Interests Represented by Preferred Stock [Table Text Block]	Shares in thousands Number of Shares Authorized 23,000 $4.50 Series, callable at $120 1,673 $3.50 Series, callable at $102 700
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	(In millions) Cumulative Translation Adjustment 1 Derivative Instruments Pension Benefit Plans Other Benefit Plans Total 2022 Balance January 1, 2022 $ (2,543) $ 72 $ (396) $ (31) $ (2,898) Other comprehensive income (loss) before reclassifications 91 (13) 8 3 89 Amounts reclassified from accumulated other comprehensive income (loss) — (12) — — (12) Net other comprehensive income (loss) 91 (25) 8 3 77 Balance March 31, 2022 $ (2,452) $ 47 $ (388) $ (28) $ (2,821) 2023 Balance January 1, 2023 $ (2,883) $ 80 $ (163) $ 160 $ (2,806) Other comprehensive income (loss) before reclassifications 134 (51) 3 — 86 Amounts reclassified from accumulated other comprehensive income (loss) — (16) (1) (2) (19) Net other comprehensive income (loss) 134 (67) 2 (2) 67 Balance March 31, 2023 $ (2,749) $ 13 $ (161) $ 158 $ (2,739) 1. The cumulative translation adjustment gain for the three months ended March 31, 2023 was primarily driven by the weakening of the USD against the European Euro ("EUR"), Brazilian Real ("BRL"), Mexican Peso ("MXN"), and Swiss Franc ("CHF"). The cumulative translation adjustment gain for the three months ended March 31, 2022 was primarily driven by the weakening of the USD against the Brazilian Real ("BRL") partially offset by the strengthening of the USD against the European Euro ("EUR") and Swiss Franc ("CHF").
Tax (Expense) Benefit of Other Comprehensive (Loss) Income	(In millions) Three Months Ended 2023 2022 Derivative instruments $ 27 $ (1) Pension benefit plans - net — (2) Other benefit plans - net — 3 (Provision for) benefit from income taxes related to other comprehensive income (loss) items $ 27 $ —
Reclassification out of Accumulated Other Comprehensive (Loss) Income [Table Text Block]	(In millions) Three Months Ended 2023 2022 Derivative Instruments 1 : $ (21) $ (15) Tax (benefit) expense 2 5 3 After-tax $ (16) $ (12) Amortization of pension benefit plans: Prior service (benefit) cost 3,4 $ (1) $ (1) Actuarial (gains) losses 3,4 — 1 Total before tax $ (1) $ — Tax (benefit) expense 2 — — After-tax $ (1) $ — Amortization of other benefit plans: Actuarial (gains) loss 3,4 (2) — Total before tax $ (2) $ — Tax (benefit) expense 2 — — After-tax $ (2) $ — Total reclassifications for the period, after-tax $ (19) $ (12) 1. Reflected in cost of goods sold in the interim Consolidated Statements of Operations. 2. Reflected in provision for (benefit from) income taxes from continuing operations in the interim Consolidated Statements of Operations. 3. These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, for additional information.

Pension Plans and Other Post _2

Pension Plans and Other Post Employment Benefit Plans (Tables)	3 Months Ended
	Mar. 31, 2023
Retirement Benefits [Abstract]
Schedule of Net Benefit Costs [Table Text Block]	Three Months Ended (In millions) 2023 2022 Defined Benefit Pension Plans: Service cost $ 5 $ 4 Interest cost 174 108 Expected return on plan assets (152) (190) Amortization of unrecognized (gain) loss — 1 Amortization of prior service (benefit) cost (1) (1) Net periodic benefit (credit) cost $ 26 $ (78) Other Post Employment Benefits: Interest cost $ 12 $ 7 Amortization of unrecognized (gain) loss (2) — Net periodic benefit (credit) cost $ 10 $ 7

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2023
Derivative [Line Items]
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]	Notional Amounts (In millions) March 31, 2023 December 31, 2022 March 31, 2022 Derivatives designated as hedging instruments: Foreign currency contracts $ 470 $ 953 $ 1,043 Commodity contracts $ 786 $ 1,167 $ 531 Derivatives not designated as hedging instruments: Foreign currency contracts $ 2,320 $ 430 $ 1,106 Commodity contracts $ 108 $ 9 $ 81
Fair Value of Derivatives Instruments	March 31, 2023 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the interim Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Commodity contracts Other current assets $ 2 $ — $ 2 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 41 (35) 6 Total asset derivatives $ 43 $ (35) $ 8 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 21 $ — $ 21 Commodity contracts Accrued and other current liabilities 10 — 10 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 66 (35) 31 Commodity contracts Accrued and other current liabilities 5 — 5 Total liability derivatives $ 102 $ (35) $ 67 December 31, 2022 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Other current assets $ 41 $ — $ 41 Commodities Contracts Other current assets 4 — 4 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 51 (40) 11 Total asset derivatives $ 96 $ (40) $ 56 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 9 $ — $ 9 Commodity contracts Accrued and other current liabilities 3 — 3 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 58 (40) 18 Total liability derivatives $ 70 $ (40) $ 30 March 31, 2022 (In millions) Balance Sheet Location Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in the interim Consolidated Balance Sheet Asset derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Other current assets $ 16 $ — $ 16 Commodity Contracts Other current assets 5 — 5 Derivatives not designated as hedging instruments: Foreign currency contracts Other current assets 21 (28) (7) Commodity contracts Other current assets 3 — 3 Total asset derivatives $ 45 $ (28) $ 17 Liability derivatives: Derivatives designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities $ 80 $ — $ 80 Derivatives not designated as hedging instruments: Foreign currency contracts Accrued and other current liabilities 114 (28) 86 Commodity contracts Accrued and other current liabilities 3 — 3 Total liability derivatives $ 197 $ (28) $ 169
Effect of Derivatives	Amount of Gain (Loss) Recognized in OCI - Pre-Tax 1 Three Months Ended March 31, (In millions) 2023 2022 Derivatives designated as hedging instruments: Net investment hedges: Foreign currency contracts $ — $ 7 Cash flow hedges: Foreign currency contracts (15) (102) Commodity contracts (58) 86 Total derivatives designated as hedging instruments $ (73) $ (9) 1. OCI is defined as other comprehensive income (loss). Amount of Gain (Loss) Recognized in Income - Pre-Tax 1 Three Months Ended March 31, (In millions) 2023 2022 Derivatives designated as hedging instruments: Cash flow hedges: Foreign currency contracts 2 $ 2 $ (3) Commodity contracts 2 19 18 Total derivatives designated as hedging instruments $ 21 $ 15 Derivatives not designated as hedging instruments: Foreign currency contracts 3 $ (3) $ (53) Foreign currency contracts 2 (12) (36) Commodity contracts 2 (1) (22) Commodity contracts 3 (3) — Total derivatives not designated as hedging instruments (19) (111) Total derivatives $ 2 $ (96) 1. For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period. 2. Recorded in cost of goods sold in the interim Consolidated Statements of Operations.
Commodity Contract [Member]
Derivative [Line Items]
After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	Three Months Ended (In millions) 2023 2022 Beginning balance $ 55 $ 47 Additions and revaluations of derivatives designated as cash flow hedges (41) 63 Clearance of hedge results to earnings (15) (14) Ending balance $ (1) $ 96
Foreign Currency Contract [Member]
Derivative [Line Items]
After-Tax Effect of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	Three Months Ended (In millions) 2023 2022 Beginning balance $ 10 $ 32 Additions and revaluations of derivatives designated as cash flow hedges (10) (82) Clearance of hedge results to earnings (1) 2 Ending balance $ (1) $ (48)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value of Assets and Liabilities Measured on Recurring Basis	March 31, 2023 December 31, 2022 March 31, 2022 (In millions) Level 2 2 Level 2 2 Level 1 1 Level 2 2 Assets at fair value: Marketable securities $ 85 $ 124 $ — $ 290 Derivatives relating to: 3 Foreign currency 41 92 — 37 Commodity contracts 2 4 — 8 Equity Securities 4 — — 29 — Total assets at fair value $ 128 $ 220 $ 29 $ 335 Liabilities at fair value: Derivatives relating to: 3 Foreign currency 87 67 — 194 Commodity contracts 15 3 — 3 Total liabilities at fair value $ 102 $ 70 $ — $ 197 1. Reflects quoted prices in active markets for identical items. 2. Reflects significant other observable inputs. 3. See Note 16 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets. 4. The company's equity securities are included in other assets in the interim Consolidated Balance Sheets.

Segment Reporting (Tables)

Segment Reporting (Tables)	3 Months Ended
	Mar. 31, 2023
Segment Reporting Information [Line Items]
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions) Three Months Ended 2023 2022 Income (loss) from continuing operations after income taxes $ 607 $ 577 Provision for (benefit from) income taxes on continuing operations 169 121 Income (loss) from continuing operations before income taxes 776 698 Depreciation and amortization 287 307 Interest income (40) (15) Interest expense 31 9 Exchange (gains) losses 36 47 Non-operating (benefits) costs 43 (65) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges 15 36 Significant items (benefit) charge 83 22 Corporate expenses 24 21 Segment operating EBITDA $ 1,255 $ 1,060
Schedule of Segment Reporting Information, by Segment [Table Text Block]	As of and for the Three Months Ended March 31, (In millions) Seed Crop Protection Total 2023 Net sales $ 2,695 $ 2,189 $ 4,884 Segment operating EBITDA $ 652 $ 603 $ 1,255 Segment assets 1 $ 23,966 $ 17,584 $ 41,550 2022 Net sales $ 2,524 $ 2,077 $ 4,601 Segment operating EBITDA $ 569 $ 491 $ 1,060 Segment assets 1 $ 24,146 $ 14,144 $ 38,290 1. Segment assets at December 31, 2022 were $22,952 million and $14,097 million for Seed and Crop Protection, respectively.
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	Segment assets to total assets (in millions) March 31, 2023 December 31, 2022 March 31, 2022 Total segment assets $ 41,550 $ 37,049 $ 38,290 Corporate assets 3,950 5,569 4,343 Total assets $ 45,500 $ 42,618 $ 42,633
Schedule of Additional Segment Details [Table Text Block]	(In millions) Seed Crop Protection Corporate Total For the Three Months Ended March 31, 2023 Restructuring and asset related charges - net 1 $ (21) $ (6) $ (6) $ (33) Estimated settlement expense 2 — (49) — (49) Inventory write-offs 3 (4) — — (4) Gain (loss) on sale of assets and equity investments 3 — 3 — 3 Seed sale associated with Russia Exit 3,4 19 — — 19 Acquisition-related costs 5 — (19) — (19) Total $ (6) $ (71) $ (6) $ (83) (In millions) Seed Crop Protection Corporate Total For the Three Months Ended March 31, 2022 Restructuring and asset related charges - net 1 $ (5) $ 2 $ (2) $ (5) Estimated settlement expense 2 — (17) — (17) Total $ (5) $ (15) $ (2) $ (22) 1. Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information. 2. Consists of estimated Lorsban® related charges. 3. Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. 4. Includes a benefit of $19 million relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the company was contractually required to purchase. It consists of $41 million of net sales and $22 million of cost of goods sold. 5. Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up. See Note 3 - Business Combinations, to the interim Consolidated Financial Statements, for additional information.

EID Segment FN (Tables)

EID Segment FN (Tables)	3 Months Ended
	Mar. 31, 2023
Segment Reporting Information [Line Items]
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	Reconciliation to interim Consolidated Financial Statements Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions) Three Months Ended 2023 2022 Income (loss) from continuing operations after income taxes $ 607 $ 577 Provision for (benefit from) income taxes on continuing operations 169 121 Income (loss) from continuing operations before income taxes 776 698 Depreciation and amortization 287 307 Interest income (40) (15) Interest expense 31 9 Exchange (gains) losses 36 47 Non-operating (benefits) costs 43 (65) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges 15 36 Significant items (benefit) charge 83 22 Corporate expenses 24 21 Segment operating EBITDA $ 1,255 $ 1,060
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	Segment assets to total assets (in millions) March 31, 2023 December 31, 2022 March 31, 2022 Total segment assets $ 41,550 $ 37,049 $ 38,290 Corporate assets 3,950 5,569 4,343 Total assets $ 45,500 $ 42,618 $ 42,633
EID [Member]
Segment Reporting Information [Line Items]
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	Income (loss) from continuing operations after income taxes to segment operating EBITDA (In millions) Three Months Ended 2023 2022 Income (loss) from continuing operations after income taxes $ 597 $ 570 Provision for (benefit from) income taxes on continuing operations 166 119 Income (loss) from continuing operations before income taxes 763 689 Depreciation and amortization 287 307 Interest income (40) (15) Interest expense 44 18 Exchange (gains) losses 36 47 Non-operating (benefits) costs 43 (65) Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges 15 36 Significant items (benefit) charge 83 22 Corporate expenses 24 21 Segment operating EBITDA $ 1,255 $ 1,060

Summary of Significant Accoun_3

Summary of Significant Accounting Policies Summary of Accounting Policies (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Foreign Exchange Impact on Income (Loss) from Continuing Operations	$ 10
Percentage deterioration of the official Peso to USD exchange rate	10%
Argentina Percentage annual sales and EBITDA	5%

Business Combinations and Ass_3

Business Combinations and Asset Acquisitions (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 01, 2023	Dec. 31, 2022	Mar. 31, 2022
Asset Acquisition [Line Items]
Goodwill	$ 10,508		$ 9,962	$ 10,109
Stoller
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Major Class Name [Domain]		$ 655
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life	13 years
Asset Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 1,224
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents		95
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables		238
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory		86
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other		26
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment		51
Goodwill		381
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill		655
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets		7
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets		8
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets		1,547
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt		59
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable		25
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities		2
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other		60
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt		3
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities		154
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other		20
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities		323
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net		1,224
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Buildings		19
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment		25
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land		5
Business combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Construction in Progress		2
Acquired Indefinite-Lived Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets		0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill		655
Stoller | In Process Research and Development [Member]
Acquired Indefinite-Lived Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets		0
Symborg
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Major Class Name [Domain]		284
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life	12 years
Asset Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$ 370
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents		0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables		16
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory		10
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other		1
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment		3
Goodwill		138
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill		298
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets		0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets		2
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets		468
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt		0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable		12
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities		0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other		12
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt		0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities		74
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other		0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities		98
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net		370
Acquired Indefinite-Lived Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets		14
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill		298
Symborg | In Process Research and Development [Member]
Acquired Indefinite-Lived Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets		14
Developed Technology Rights [Member] | Stoller
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Major Class Name [Domain]		121
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life	14 years
Developed Technology Rights [Member] | Symborg
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Major Class Name [Domain]		229
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life	12 years
Trademarks and Trade Names [Member] | Stoller
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Major Class Name [Domain]		43
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life	15 years
Trademarks and Trade Names [Member] | Symborg
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Major Class Name [Domain]		55
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life	12 years
Customer-Related Intangible Assets [Member] | Stoller
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Major Class Name [Domain]		491
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life	13 years
Customer-Related Intangible Assets [Member] | Symborg
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Major Class Name [Domain]		$ 0

Revenue Narrative (Details)

Revenue Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 126	$ 131	$ 120
Minimum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Maximum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	6 years

Revenue Contract Balances (Deta

Revenue Contract Balances (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Accounts and notes receivable - trade	[1]	$ 7,334	$ 6,029	$ 4,261
Contract assets - current	[2]	26	24	26
Contract assets - noncurrent	[3]	63	58	64
Deferred Revenue		2,712	2,435	3,388
Deferred revenue recognized during the period		1,201	1,339
Accrued and Other Current Liabilities [Member]
Disaggregation of Revenue [Line Items]
Deferred Revenue		2,712	2,435	3,388
Other noncurrent obligations
Disaggregation of Revenue [Line Items]
Deferred Revenue	[4]	$ 103	$ 104	$ 107
[1]Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets.[2]Included in other current assets in the interim Consolidated Balance Sheets.[3]Included in other assets in the interim Consolidated Balance Sheets.[4]Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Revenue Disaggregation of Reven

Revenue Disaggregation of Revenue - Principal Product Groups (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Net Sales	$ 4,884	$ 4,601
Seed [Member]
Disaggregation of Revenue [Line Items]
Net Sales	2,695	2,524
Seed [Member] | Corn [Member]
Disaggregation of Revenue [Line Items]
Net Sales	1,979	1,930
Seed [Member] | Soybean [Member]
Disaggregation of Revenue [Line Items]
Net Sales	269	172
Seed [Member] | Other oilseeds [Member]
Disaggregation of Revenue [Line Items]
Net Sales	301	277
Seed [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Net Sales	146	145
Crop Protection [Member]
Disaggregation of Revenue [Line Items]
Net Sales	2,189	2,077
Crop Protection [Member] | Other [Member]
Disaggregation of Revenue [Line Items]
Net Sales	179	150
Crop Protection [Member] | Herbicides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	1,242	1,205
Crop Protection [Member] | Insecticides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	409	418
Crop Protection [Member] | Fungicides [Member]
Disaggregation of Revenue [Line Items]
Net Sales	$ 359	$ 304

Revenue Disaggregation of Rev_2

Revenue Disaggregation of Revenue - Geography (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Net Sales		$ 4,884	$ 4,601
Seed [Member]
Disaggregation of Revenue [Line Items]
Net Sales		2,695	2,524
Seed [Member] | North America
Disaggregation of Revenue [Line Items]
Net Sales	[1]	1,323	1,184
Seed [Member] | EMEA
Disaggregation of Revenue [Line Items]
Net Sales	[2]	1,012	926
Seed [Member] | Latin America
Disaggregation of Revenue [Line Items]
Net Sales		259	323
Seed [Member] | Asia Pacific
Disaggregation of Revenue [Line Items]
Net Sales		101	91
Crop Protection [Member]
Disaggregation of Revenue [Line Items]
Net Sales		2,189	2,077
Crop Protection [Member] | North America
Disaggregation of Revenue [Line Items]
Net Sales	[1]	879	821
Crop Protection [Member] | EMEA
Disaggregation of Revenue [Line Items]
Net Sales	[2]	801	656
Crop Protection [Member] | Latin America
Disaggregation of Revenue [Line Items]
Net Sales		293	327
Crop Protection [Member] | Asia Pacific
Disaggregation of Revenue [Line Items]
Net Sales		$ 216	$ 273
[1]Represents U.S. & Canada.[2]Europe, Middle East, and Africa ("EMEA").

Restructuring and Asset Relat_3

Restructuring and Asset Related Charges - 2022 Restructuring Actions (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		$ 33	$ 5
2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		341
Restructuring Reserve, Beginning Balance		83
Restructuring and Asset related charges, net	[1],[2]	11
Payments for Restructuring		(23)
Asset write-offs and adjustments		(7)
Restructuring Reserve, Ending Balance		64
Restructuring payments, inception to date		115
2022 Restructuring Actions | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		350
Future Cash Payments		180
2022 Restructuring Actions | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		420
Future Cash Payments		210
2022 Restructuring Actions | Severance and Related Benefit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		115
Restructuring Reserve, Beginning Balance		71
Restructuring and Asset related charges, net		4
Payments for Restructuring		(12)
Asset write-offs and adjustments		0
Restructuring Reserve, Ending Balance		63
2022 Restructuring Actions | Severance and Related Benefit Costs | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		105
2022 Restructuring Actions | Severance and Related Benefit Costs | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		120
2022 Restructuring Actions | Contract Termination
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		57
Restructuring Reserve, Beginning Balance	[3]	12
Restructuring and Asset related charges, net	[3],[4]	0
Payments for Restructuring	[3]	(11)
Asset write-offs and adjustments	[3]	0
Restructuring Reserve, Ending Balance	[3]	1
2022 Restructuring Actions | Contract Termination | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		65
2022 Restructuring Actions | Contract Termination | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		80
2022 Restructuring Actions | Asset Related Charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		111
Restructuring Reserve, Beginning Balance		0
Restructuring and Asset related charges, net		7
Payments for Restructuring		0
Asset write-offs and adjustments		(7)
Restructuring Reserve, Ending Balance		0
2022 Restructuring Actions | Asset Related Charges [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		125
2022 Restructuring Actions | Asset Related Charges [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		150
2022 Restructuring Actions | Other [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		58
2022 Restructuring Actions | Other [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		55
2022 Restructuring Actions | Other [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost		70
2022 Restructuring Actions- Russia Exit
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		49
2022 Restructuring Actions- Russia Exit | Severance and Related Benefit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		6
2022 Restructuring Actions- Russia Exit | Contract Termination
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		26
2022 Restructuring Actions- Russia Exit | Asset Related Charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		6
2022 Restructuring Actions- Russia Exit | inventory write-offs | Cost of Goods Sold
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		3
2022 Restructuring Actions- Russia Exit | Settlement Cost | Other Income
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date		8
Seed [Member] | 2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		6
Crop Protection [Member] | 2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		1
Corporate Segment | 2022 Restructuring Actions
Restructuring Cost and Reserve [Line Items]
Restructuring and Asset related charges, net		$ 4
[1]This amount excludes other pre-tax charges recorded during the three months ended March 31, 2023 impacting the Seed segment included in cost of goods sold and other income (expense) - net, in the company's interim Consolidated Statement of Operations, relating to inventory write-offs and the loss on the sale of the company's interest in an equity investment.[2]This amount excludes other pre-tax charges recorded during the three months ended March 31, 2023 included in cost of goods sold and other income (expense) - net, in the company's interim Consolidated Statement of Operations, relating to inventory write-offs and the loss on the sale of the company's interest in an equity investment.[3]The liability for contract terminations includes lease obligations. The cash impact of these obligations will be substantially complete by the end of 2023[4]Contract terminations includes early lease terminations.

Restructuring and Asset Relat_4

Restructuring and Asset Related Charges Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Other Asset Related [Member]
Restructuring Cost and Reserve [Line Items]
Accelerated Prepaid Royalty Amortization Expense	$ 16	$ 6

Supplementary Information Other

Supplementary Information Other Income (Expense) - Net (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Interest income		$ 40	$ 15
Equity in earnings (losses) of affiliates - net		3	10
Net gain (loss) on sales of businesses and other assets		(1)	(3)
Net exchange gains (losses)	[1]	(36)	(47)
Non-operating pension and other post employment benefit credit	[2]	(31)	75
Miscellaneous expenses - net	[3]	46	(33)
Other income - net		(71)	17
Hedging Program [Member]
Net exchange gains (losses)		(6)	(53)
Hedging Program [Member] | Argentine Peso Devaluation [Member]
Net exchange gains (losses)		(21)	(15)
Subsidiary Monetary Position
Net exchange gains (losses)		$ (30)	$ 6
[1]Includes net pre-tax exchange gains (losses) of $(21) million and $(15) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2023 and 2022, respectively.[2]Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)).[3]Miscellaneous income (expenses) - net for the three months ended March 31, 2023 and 2022 includes estimated settlement reserves, gains on the sale of assets, a loss on the sale of the company’s interest in an equity investment, and other items. Additionally, the three months ended March 31, 2022 includes losses associated with a previously held equity investment.

Supplementary Information Forei

Supplementary Information Foreign Currency Exchange Gain (Loss) (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Foreign Currency Exchange Gain (Loss) [Line Items]
Pre-tax exchange (losses) gains - net	[1]	$ (36)	$ (47)
Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit		11	9
Foreign Currency Transaction (Loss) Gain After Tax		(25)	(38)
Subsidiary Monetary Position
Foreign Currency Exchange Gain (Loss) [Line Items]
Pre-tax exchange (losses) gains - net		(30)	6
Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit		9	(4)
Foreign Currency Transaction (Loss) Gain After Tax		(21)	2
Hedging Program [Member]
Foreign Currency Exchange Gain (Loss) [Line Items]
Pre-tax exchange (losses) gains - net		(6)	(53)
Foreign Currency Transaction (Loss) Gain Tax (Expense) Benefit		2	13
Foreign Currency Transaction (Loss) Gain After Tax		$ (4)	$ (40)
[1]Includes net pre-tax exchange gains (losses) of $(21) million and $(15) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2023 and 2022, respectively.

Supplementary Information Recon

Supplementary Information Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Millions	Mar. 31, 2023		Dec. 31, 2022	Mar. 31, 2022		Dec. 31, 2021
Restricted Cash and Cash Equivalents Items [Line Items]
Cash and cash equivalents	$ 1,646		$ 3,191	$ 2,031
Restricted Cash Equivalents	422		427	354
Total Cash, Cash Equivalents and Restricted Cash Equivalents	$ 2,068	[1]	$ 3,618	$ 2,385	[1]	$ 4,836
[1]See page 16 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.

Income Taxes Income Tax Narrati

Income Taxes Income Tax Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Net tax benefits	$ 12	$ 35
Effective Income Tax Rate	21.80%	17.30%

Earnings Per Share Net Income f

Earnings Per Share Net Income for Earnings Per Share Calculations - Basic and Diluted (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Income (loss) from continuing operations after income taxes	$ 607	$ 577
Net income (loss) Attributable to Noncontrolling Interest, Continuing Operations	4	3
Net income (loss) from Continuing Operations Available to Common Shareholders	603	574
Income (loss) from discontinued operations after income taxes	(8)	(10)
Net income (loss) Available to Common Stockholders	$ 595	$ 564

Earnings Per Share Earnings Per

Earnings Per Share Earnings Per Share Calculations - Basic (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Basic earnings (loss) per share of common stock from continuing operations	$ 0.85	$ 0.79
Basic earnings (loss) per share of common stock from discontinued operations	$ (0.01)	$ (0.01)
Basic earnings (loss) per share of common stock	$ 0.84	$ 0.78

Earnings Per Share Earnings P_2

Earnings Per Share Earnings Per Share Calculations - Diluted (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Abstract]
Diluted earnings (loss) per share of common stock from continuing operations	$ 0.84	$ 0.79
Diluted earnings (loss) per share of common stock from discontinued operations	$ (0.01)	$ (0.01)
Diluted earnings (loss) per share of common stock	$ 0.83	$ 0.78

Earnings Per Share Share Count

Earnings Per Share Share Count Information (Details) - shares shares in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Earnings Per Share [Line Items]
Weighted Average Common Shares - basic		712.9	727
Dilutive effect of equity compensation plans	[1]	3.3	3.9
Weighted Average Common Shares - diluted		716.2	730.9
Potential shares of common stock excluded from EPS calculations	[2]	2.7	2.5
[1]Diluted earnings (loss) per share considers the impact of potentially dilutive securities except in periods in which there is a loss because the inclusion of the potential common shares would have an anti-dilutive effect.[2]These outstanding potential shares of common stock relating to stock options, restricted stock units and performance-based restricted stock units were excluded from the calculation of diluted earnings (loss) per share because (i) the effect of including them would have been anti-dilutive; and (ii) the performance metrics have not yet been achieved for the outstanding potential shares relating to performance-based restricted stock units, which are deemed to be contingently issuable.

Accounts and Notes Receivable_3

Accounts and Notes Receivable (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Receivable - trade	[1]	$ 6,883	$ 5,603	$ 4,168
Notes receivable - trade	[1],[2]	451	426	93
Other	[3]	1,344	1,246	1,440
Accounts and notes receivable - net		8,678	7,275	5,701
Accounts Receivable, Allowance for Credit Loss, Current		207	232	194	$ 210
Amounts due from nonconsolidated affiliates		137	124	148
Factoring Agreement [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Trade Receivables Sold		8	17
Trade receivables sold the remain outstanding with an element of recourse		$ 19	$ 130	$ 37
[1]Accounts receivable – trade and notes receivable - trade are net of allowances of $207 million, $194 million, and $232 million at March 31, 2023, December 31, 2022, and March 31, 2022, respectively.[2]Notes receivable – trade primarily consists of receivables for deferred payment loan programs for the sale of seed and chemical products to customers. These loans have terms of one year or less and are primarily concentrated in North America. The company maintains a rigid approval process for extending credit to customers in order to manage overall risk and exposure associated with credit losses. As of March 31, 2023, December 31, 2022, and March 31, 2022 there were no significant impairments related to current loan agreements.[3]Other includes receivables in relation to indemnification assets, value added tax, general sales tax and other taxes. No individual group represents more than 5 percent of total receivables. In addition, Other includes amounts due from nonconsolidated affiliates of $137 million, $148 million, and $124 million as of March 31, 2023, December 31, 2022, and March 31, 2022, respectively.

Accounts and Notes Receivable A

Accounts and Notes Receivable Allowance Rollforward (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Receivables [Abstract]
Accounts Receivable, Allowance for Credit Loss, Beginning Balance	$ 194	$ 210
Net Provision for Credit Losses	10	5
Write-offs charged against allowance/ other	3	17
Accounts Receivable, Allowance for Credit Loss, Ending Balance	$ 207	$ 232

Inventories Schedule of Invento

Inventories Schedule of Inventory (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Inventory [Line Items]
Finished Products	$ 3,650	$ 3,260	$ 2,691
Semi-finished Products	2,023	2,689	1,635
Raw Materials and Supplies	912	862	660
Total inventories	$ 6,585	$ 6,811	$ 4,986

Property, Plant and Equipment S

Property, Plant and Equipment Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 8,633	$ 8,551	$ 8,483
Accumulated Depreciation	$ (4,362)	$ (4,297)	$ (4,150)

Goodwill (Details)

Goodwill (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Goodwill [Line Items]
Goodwill, Beginning Balance	$ 9,962
Goodwill, Acquired During Period	519	[1]
Goodwill, Currency Translation Adjustments	27
Goodwill, Ending Balance	10,508
Crop Protection [Member]
Goodwill [Line Items]
Goodwill, Beginning Balance	4,618
Goodwill, Acquired During Period	519	[1]
Goodwill, Currency Translation Adjustments	13
Goodwill, Ending Balance	5,150
Seed [Member]
Goodwill [Line Items]
Goodwill, Beginning Balance	5,344
Goodwill, Acquired During Period	0
Goodwill, Currency Translation Adjustments	14
Goodwill, Ending Balance	$ 5,358
[1]On March 1, 2023, the company completed the acquisitions of Stoller and Symborg, which are included in the crop protection segment. See Note 3 – Business Combinations, to the interim Consolidated Financial Statements, for additional information.

Other Intangible Assets Other I

Other Intangible Assets Other Intangible Assets (Details) - USD ($) $ in Millions		Mar. 31, 2023	[1]	Dec. 31, 2022	Mar. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		$ 13,045		$ 12,092	$ 12,594
Finite-Lived Intangible Assets, Accumulated Amortization		(2,922)		(2,763)	(2,739)
Finite-Lived Intangible Assets, Net		10,123		9,329	9,855
Indefinite-lived Intangible Assets (Excluding Goodwill)		14		10	10
Intangible Assets, Gross (Excluding Goodwill)		13,059		12,102	12,604
Total other intangible assets		10,137		9,339	9,865
In Process Research and Development [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets (Excluding Goodwill)		14		10	10
Germplasm [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		6,291		6,291	6,265
Finite-Lived Intangible Assets, Accumulated Amortization		(890)		(826)	(634)
Finite-Lived Intangible Assets, Net		5,401		5,465	5,631
Customer-Related Intangible Assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		2,407		1,912	1,953
Finite-Lived Intangible Assets, Accumulated Amortization		(617)		(585)	(515)
Finite-Lived Intangible Assets, Net		1,790		1,327	1,438
Developed Technology Rights [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		1,845		1,485	1,485
Finite-Lived Intangible Assets, Accumulated Amortization		(868)		(830)	(716)
Finite-Lived Intangible Assets, Net		977		655	769
Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		2,107		2,009	2,011
Finite-Lived Intangible Assets, Accumulated Amortization		(271)		(251)	(192)
Finite-Lived Intangible Assets, Net		1,836		1,758	1,819
Favorable Supply Contract [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	[2]				475
Finite-Lived Intangible Assets, Accumulated Amortization	[2]				(420)
Finite-Lived Intangible Assets, Net	[2]				55
Other Intangible Assets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	[3]	395		395	405
Finite-Lived Intangible Assets, Accumulated Amortization	[3]	(276)		(271)	(262)
Finite-Lived Intangible Assets, Net	[3]	$ 119		$ 124	$ 143
[1]Includes the intangible assets acquired in connection with the Stoller and Symborg acquisitions, which were completed on March 1, 2023. See Note 3 – Business Combinations, to the interim Consolidated Financial Statements, for additional information.[2]Effective November 1, 2022, the favorable supply contracts expired and were fully amortized.[3]Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.

Other Intangible Assets Future

Other Intangible Assets Future Amortization Expense (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 160	$ 179
Continuing Operations [Member]
Finite-Lived Intangible Assets [Line Items]
Pre-tax amortization expense, remainder of 2023	520
Pre-tax amortization expense, 2024	679
Pre-tax amortization expense, 2025	642
Pre-tax amortization expense, 2026	631
Pre-tax amortization expense, 2027	571
Pre-tax amortization expense, 2028	$ 549

Short-Term Borrowings, Long-T_3

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Short-term borrowings and finance lease obligations (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Short-term Debt [Line Items]
Long-term Debt Payable within one year	$ 49	$ 0	$ 0
Finance Lease, Liability, Current	1	1	1
Short-term borrowings and finance lease obligations	3,787	24	1,018
Commercial Paper [Member]
Short-term Debt [Line Items]
Short-term borrowings	2,680	0	984
Other loans - various currencies [Member]
Short-term Debt [Line Items]
Short-term borrowings	57	23	33
364-day Revolving Credit Facilities due 2023 | Securities Sold under Agreements to Repurchase [Member]
Short-term Debt [Line Items]
Short-term borrowings	$ 1,000	$ 0	$ 0

Short-Term Borrowings, Long-T_4

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Long-term Debt (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Debt Instrument [Line Items]
Long-term Debt Payable within one year	$ 49	$ 0	$ 0
Long-term Debt and Lease Obligation	1,241	1,283	1,154
Finance Lease, Liability, Noncurrent	3	2	3
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	7	7	9
Line of Credit Facility, Maximum Borrowing Capacity	6,000
Line of Credit Facility, Remaining Borrowing Capacity	5,000
Foreign Currency Loans
Debt Instrument [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	75
Revolving Credit Facilities due 2027
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	3,000
Line of Credit Facility, Remaining Borrowing Capacity	3,000
Revolving Credit Facilities due 2025 [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	2,000
Line of Credit Facility, Remaining Borrowing Capacity	2,000
364-day Revolving Credit Facilities due 2023
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	1,000
Line of Credit Facility, Remaining Borrowing Capacity	0
Medium-term Notes [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 107	$ 107	$ 107
Long-term Debt, Weighted Average Interest Rate, at Point in Time	4.62%	4.27%	0.35%
Loans Payable [Member] | Notes Maturing 2025 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 500	$ 500	$ 500
Long-term Debt, Weighted Average Interest Rate, at Point in Time	1.70%	1.70%	1.70%
Loans Payable [Member] | Notes Maturing 2030 [Domain]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 500	$ 500	$ 500
Long-term Debt, Weighted Average Interest Rate, at Point in Time	2.30%	2.30%	2.30%
Loans Payable [Member] | Foreign Currency Loans
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 187	$ 181	$ 53
Foreign Currency Loans
Debt Instrument [Line Items]
Long-term Debt, Weighted Average Interest Rate, at Point in Time	14.80%	14.80%	15%
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Long-term Debt, Fair Value	$ 1,198	$ 1,172	$ 1,107

Short-Term Borrowings, Long-T_5

Short-Term Borrowings, Long-Term Debt and Available Credit Facilities Repurchase Facility and Revolving Credit Facilities (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	$ 5,000
Line of Credit Facility, Maximum Borrowing Capacity	6,000
Proceeds from debt	626	$ 311
Repayments of Long-term Debt	56	0
Foreign Currency Loans
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	75
Revolving Credit Facilities due 2022
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,000
Debt Instrument, Term	3 years
Revolving Credit Facilities due 2024 [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Term	5 years
Revolving Credit Facilities due 2025 [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	$ 2,000
Line of Credit Facility, Maximum Borrowing Capacity	$ 2,000
Revolving Credit Facilities due 2025 [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Adjusted Term SOFR	0.10%
Revolving Credit Facilities due 2027
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	$ 3,000
Line of Credit Facility, Maximum Borrowing Capacity	$ 3,000
Revolving Credit Facility
Line of Credit Facility [Line Items]
Ratio of Indebtedness to Net Capital	0.60
364-day Revolving Credit Facilities due 2023
Line of Credit Facility [Line Items]
Line of Credit Facility, Remaining Borrowing Capacity	$ 0
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,000
Debt Instrument, Term	364 days
Ratio of Indebtedness to Net Capital	0.60
364-day Revolving Credit Facilities due 2023 | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Line of Credit Facility [Line Items]
Adjusted Term SOFR	0.10%
Securities Sold under Agreements to Repurchase [Member] | 364-day Revolving Credit Facilities due 2023
Line of Credit Facility [Line Items]
Short-term borrowings	$ 1,000	$ 0	$ 0

Commitments and Contingent Li_3

Commitments and Contingent Liabilities - Supplier Finance (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Supplier Finance Program [Line Items]
Supplier Finance Program, Obligation, Current	$ 165	$ 220	$ 180

Commitments and Contingent Li_4

Commitments and Contingent Liabilities Guarantee Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Guarantor Obligations [Line Items]
Guarantee Obligations	$ 79	$ 88	$ 105
Greater than one year
Guarantor Obligations [Line Items]
Guarantee Obligations	15
Factoring Agreement [Member]
Guarantor Obligations [Line Items]
Guarantee Obligations	9	16	21
Agreements with lenders to provide financing for select customers [Member]
Guarantor Obligations [Line Items]
Accounts Receivable, after Allowance for Credit Loss	$ 89	$ 202	$ 180

Commitments and Contingent Li_5

Commitments and Contingent Liabilities Chemours (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)	Dec. 31, 2019 USD ($) lawsuits	Sep. 30, 2030 USD ($)	Dec. 31, 2028 USD ($)	Sep. 30, 2024 USD ($)
PFAS [Member]
Loss Contingencies [Line Items]
Escrow Account Balance				$ 700
PFAS [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Cost Sharing Arrangement Term	20 years
Qualified Spend and Escrow Account Contribution Threshold	$ 4,000
Corteva and DuPont stray liability threshold for PFAS	300
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party		$ 670
Lawsuits alleging personal injury filed | lawsuits		3,550
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Amount credited to each company's threshold	$ 150
Chemours [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Annual Escrow Deposit					$ 100
Annual Escrow Deposit, remainder of period			$ 50
Chemours [Member] | PFAS [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Total Escrow Deposit Amount			500
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	29%
Corteva [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%
Corteva [Member] | DuPont de Nemours [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%
Annual Escrow Deposit					$ 100
Annual Escrow Deposit, remainder of period			50
Escrow Account Deposit Percentage	50%
Corteva [Member] | DuPont de Nemours [Member] | PFAS [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Qualified Spend and Escrow Account Contribution Threshold	$ 2,000
Total Escrow Deposit Amount			$ 500
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	71%
DuPont de Nemours [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%
DuPont de Nemours [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Corteva and DuPont stray liability threshold for PFAS	$ 200

Commitments and Contingent Li_6

Commitments and Contingent Liabilities DuPont (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Accounts and Notes Receivable [Member]
Loss Contingencies [Line Items]
Indemnification Assets	$ 36,000,000	$ 31,000,000	$ 31,000,000
Other Assets [Member]
Loss Contingencies [Line Items]
Indemnification Assets	109,000,000	105,000,000	80,000,000
Accrued and Other Current Liabilities [Member]
Loss Contingencies [Line Items]
Indemnified Liabilities	32,000,000	31,000,000	32,000,000
Other noncurrent obligations
Loss Contingencies [Line Items]
Indemnified Liabilities	118,000,000	$ 115,000,000	$ 116,000,000
PFAS [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Corteva and DuPont stray liability threshold for PFAS	1
PFAS [Member] | Minimum [Member] | Once $300 million threshold is met [Member]
Loss Contingencies [Line Items]
De minimis threshold	1,000,000
PFAS [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Corteva and DuPont stray liability threshold for PFAS	300,000,000
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Amount credited to each company's threshold	150,000,000
Litigation Settlement [Abstract]
Escrow Balance	$ 125,000,000
Corteva [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	29%
Corteva [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%
Corteva [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability threshold	$ 200,000,000
Corteva [Member] | DuPont de Nemours [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%
DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage	71%
DuPont de Nemours [Member] | PFAS [Member]
Loss Contingencies [Line Items]
Stray liability sharing percentage for PFAS	50%
DuPont de Nemours [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability threshold	$ 200,000,000
Corteva and DuPont stray liability threshold for PFAS	$ 200,000,000

Commitments and Contingent Li_7

Commitments and Contingent Liabilities PFOA / Leach Settlement (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2023 USD ($) lawsuits	Dec. 31, 2019 USD ($) lawsuits	Dec. 31, 2004 USD ($)	Jan. 01, 2012
MDL Settlement [Domain]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 83,000,000
DuPont de Nemours and Corteva Contribution to MDL Settlement
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	27,000,000
Payments for Legal Settlements	27,000,000
PFAS [Member] | Chemours [Member]
Loss Contingencies [Line Items]
Chemours Contribution to MDL Settlement	0.50
PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Binding Settlement Agreement Class Size			80,000
Loss Contingency, Number Of Water Districts Receiving Water Treatment				6
Litigation Settlement, Liability For Medical Monitoring Program, Threshold			$ 235,000,000
Litigation Settlement, Medical Monitoring Program, Escrow Account, Disbursements To Date	2,000,000
Escrow Balance	$ 1,000,000
PFOA Matters: Drinking Water Actions [Member] | WEST VIRGINIA AND OHIO [Domain] | Settled Litigation
Loss Contingencies [Line Items]
Loss Contingency, Claims Settled, Number | lawsuits	95,000,000
PFOA Matters: Drinking Water Actions [Member] | WEST VIRGINIA AND OHIO [Domain] | Compensatory damages [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 40,000,000
PFOA Matters: Drinking Water Actions [Member] | WEST VIRGINIA AND OHIO [Domain] | Loss of consortium [Member]
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 10,000,000
PFOA Matters: Multi-District Litigation [Member]
Loss Contingencies [Line Items]
Disease Categories for MDL	6
Lawsuits alleging personal injury filed | lawsuits		3,550
Litigation Settlement, Amount Awarded to Other Party		$ 670,000,000

Commitments and Contingent Li_8

Commitments and Contingent Liabilities Other PFOA Matters / Fayetteville (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) lawsuits
Firefighting Foam [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number | lawsuits	3,900
Personal injury cases [Member] | Firefighting Foam [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	3,500
Municipal water districts | Firefighting Foam [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	300
Chemours Contribution to MDL Settlement
Loss Contingencies [Line Items]
Litigation Settlement, Amount Awarded to Other Party	$ 29
NEW YORK | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	45
NEW JERSEY | Natural Resources Damages [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	2
OHIO | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number | lawsuits	3
NORTH CAROLINA | PFOA Matters: Drinking Water Actions [Member]
Loss Contingencies [Line Items]
Loss Contingency, Number of Property Owners	100
DELAWARE | Natural Resources Damages [Member] | Corteva [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Threshold for payments to fund the NRST Trust	$ 50
Supplemental payment threshold	$ 25
Period for supplemental payment	8 years
Alabama Water Utility [Member] | Natural Resources Damages [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number	1

Commitments and Contingent Li_9

Commitments and Contingent Liabilities Environmental (Details) - USD ($) $ in Millions		Mar. 31, 2023	Jan. 28, 2022
Loss Contingencies [Line Items]
Indemnification Asset		$ 257
Accrual for Environmental Loss Contingencies	[1]	519
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1]	622
Non-PFAS
Loss Contingencies [Line Items]
Request for Remediation Funding Source ("RFS")			$ 900
Chemours related obligation subject to indemnification [Member]
Loss Contingencies [Line Items]
Indemnification Asset	[2],[3]	152
Accrual for Environmental Loss Contingencies	[1],[2],[3]	152
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1],[2],[3]	275
Discontinued Operations [Member]
Loss Contingencies [Line Items]
Indemnification Asset	[2]	24
Other discontinued or divested business obligations [Member]
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies	[1],[2]	69
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1],[2]	192
Environmental remediation liabilities primarily related to DuPont - subject to indemnity from DuPont [Member]
Loss Contingencies [Line Items]
Indemnification Asset	[3]	56
Accrual for Environmental Loss Contingencies	[1],[3]	59
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1],[3]	62
Not subject to indemnification [Member]
Loss Contingencies [Line Items]
Indemnification Asset		0
Accrual for Environmental Loss Contingencies	[1]	113
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1]	63
Indemnification liabilities related to the MOU
Loss Contingencies [Line Items]
Indemnification Asset	[4]	25
Accrual for Environmental Loss Contingencies	[1],[4]	126
Accrual for Environmental Loss Contingencies, Potential Exposure in Excess of Accrual	[1],[2],[4]	30
DuPont de Nemours [Member] | DuPont de Nemours [Member]
Loss Contingencies [Line Items]
Stray liability threshold		200
Superfund Sites [Member]
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies		59
Superfund Sites [Member] | Chemours [Member] | Indemnification Agreement [Member]
Loss Contingencies [Line Items]
Indemnification Asset		$ 35
[1]Accrual balance represents management’s best estimate of the costs of remediation and restoration, although it is reasonably possible that the potential exposure, as indicated, could range above the amounts accrued, as there are inherent uncertainties in these estimates. Accrual balance includes $59 million for remediation of Superfund sites. Amounts do not include possible impacts from the remediation elements of the EPA's October 2021 PFAS Strategic Roadmap (as applicable), except as disclosed on page 24 relating to Chemours' remediation activities at the Fayetteville Works Facility pursuant to the Consent Order with the NC DEQ. 4. Represents liabilities that are subject to the $150 million threshold and sharing agreements as discussed on page 23, under the header "Chemours / Performance Chemicals."

Stockholders' Equity Common Sto

Stockholders' Equity Common Stock (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Apr. 27, 2023	Dec. 31, 2022	Sep. 13, 2022	Aug. 05, 2021	Jun. 26, 2019
Class of Stock [Line Items]
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01	$ 0.01
Repurchase of Common Stock	$ 252	$ 235
2021 Stock Repurchase Program
Class of Stock [Line Items]
Stock Repurchased and Retired During Period, Shares	4,098	4,585
Stock Repurchase Program, Authorized Amount						$ 1,500
Repurchase of Common Stock	$ 250	$ 235
2022 Stock Repurchase Program
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount					$ 2,000
Corteva [Member]
Class of Stock [Line Items]
Common Stock, Par Value	$ 0.01						$ 0.01

Stockholders' Equity Preferred

Stockholders' Equity Preferred Stock (Details) - EID [Member] - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
$4.50 Series Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	1,673,000	1,673,000	1,673,000
Preferred Stock, Redemption Amount	$ 120	$ 120	$ 120
$3.50 Series Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized	23,000,000	23,000,000	23,000,000
Preferred Stock, Shares Issued	700,000	700,000	700,000
Preferred Stock, Redemption Amount	$ 102	$ 102	$ 102
Corteva [Member]
Class of Stock [Line Items]
Ownership interest in an entity	100%

Stockholders' Equity Other Comp

Stockholders' Equity Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		$ (2,806)
Beginning Balance		25,541	$ 25,623
Amounts Reclassified from Accumulated Other Comprehensive Loss		(19)	(12)
Other comprehensive (loss) income		67	77
Ending Balance		25,839	25,936
Ending Balance		(2,739)	(2,821)
Pension Plan
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		(163)	(396)
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax		3	8
Amounts Reclassified from Accumulated Other Comprehensive Loss		(1)	0
Other comprehensive (loss) income		2	8
Ending Balance		(161)	(388)
Other Benefit Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		160	(31)
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax		0	3
Amounts Reclassified from Accumulated Other Comprehensive Loss		(2)	0
Other comprehensive (loss) income		(2)	3
Ending Balance		158	(28)
Cumulative Translation Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		(2,883)	(2,543)
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax	[1]	134	91
Amounts Reclassified from Accumulated Other Comprehensive Loss		0	0
Other comprehensive (loss) income		134	91
Ending Balance		(2,749)	(2,452)
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		80	72
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax		(51)	(13)
Amounts Reclassified from Accumulated Other Comprehensive Loss		(16)	(12)
Other comprehensive (loss) income		(67)	(25)
Ending Balance		13	47
Total
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance		(2,806)	(2,898)
Beginning Balance		(2,806)	(2,898)
Other Comprehensive (Loss) Income, before Reclassifications, Net of Tax		86	89
Amounts Reclassified from Accumulated Other Comprehensive Loss		(19)	(12)
Other comprehensive (loss) income		67	77
Ending Balance		(2,739)	(2,821)
Ending Balance		$ (2,739)	$ (2,821)
[1]The cumulative translation adjustment gain for the three months ended March 31, 2023 was primarily driven by the weakening of the USD against the European Euro ("EUR"), Brazilian Real ("BRL"), Mexican Peso ("MXN"), and Swiss Franc ("CHF"). The cumulative translation adjustment gain for the three months ended March 31, 2022 was primarily driven by the weakening of the USD against the Brazilian Real ("BRL") partially offset by the strengthening of the USD against the European Euro ("EUR") and Swiss Franc ("CHF").

Stockholders' Equity Tax Benefi

Stockholders' Equity Tax Benefit (Expense) on Net Activity (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	$ 27	$ 0
Pension Plan
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	0	(2)
Other Benefit Plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	0	3
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Tax Benefit (Expense)	$ 27	$ (1)

Stockholders' Equity Reclassifi

Stockholders' Equity Reclassifications out of AOCI (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amounts Reclassified from Accumulated Other Comprehensive Loss		$ (19)	$ (12)
Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amounts Reclassified from Accumulated Other Comprehensive Loss		(1)	0
Other Benefit Plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Amounts Reclassified from Accumulated Other Comprehensive Loss		(2)	0
Derivative Instruments
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax	[1]	(21)	(15)
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax	[2]	5	3
Amounts Reclassified from Accumulated Other Comprehensive Loss		(16)	(12)
Actuarial (Gains) Losses | Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax	[3],[4]	0	1
Actuarial (Gains) Losses | Other Benefit Plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax	[3],[4]	(2)	0
Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax		(1)	0
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax	[2]	0	0
Amounts Reclassified from Accumulated Other Comprehensive Loss		(1)	0
Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Other Benefit Plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax		(2)	0
Reclassification from Accumulated Other Comprehensive Loss, Current Period, Tax	[2]	0	0
Amounts Reclassified from Accumulated Other Comprehensive Loss		(2)	0
Prior Service Benefit | Pension Plan
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassification from Accumulated Other Comprehensive Income (Loss), Current Period, before Tax	[3],[4]	$ (1)	$ (1)
[1]Reflected in cost of goods sold in the interim Consolidated Statements of Operations.[2]Reflected in provision for (benefit from) income taxes from continuing operations in the interim Consolidated Statements of Operations.[3]Reflected in other income (expense) - net in the interim Consolidated Statements of Operations.[4]These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit credit of the company's pension and other benefit plans. See Note 15 - Pension Plans and Other Post Employment Benefits, for additional information.

Pension Plans and Other Post _3

Pension Plans and Other Post Employment Benefit Plans Components of net periodic benefit cost (credit) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service Cost	$ 5	$ 4
Interest Cost	174	108
Expected return on plan assets	(152)	(190)
Amortization of unrecognized loss (gain)	0	1
Amortization of Prior Service Benefit	1	1
Defined Benefit Plan, Net Periodic Benefit (Credit) Cost	26	(78)
Other Benefit Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Interest Cost	12	7
Amortization of unrecognized loss (gain)	(2)	0
Defined Benefit Plan, Net Periodic Benefit (Credit) Cost	$ 10	$ 7

Financial Instruments Financial

Financial Instruments Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Cash Equivalents [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities	$ 780	$ 2,296	$ 1,414
Marketable Securities [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities	85	124	290
Other Assets [Member]
Schedule of Held-to-maturity Securities [Line Items]
Held-to-maturity securities	$ 27	$ 27	$ 53

Financial Instruments Notional

Financial Instruments Notional Amounts (Details) € in Millions, $ in Millions	Mar. 31, 2023 USD ($)	Mar. 31, 2023 EUR (€)	Dec. 31, 2022 USD ($)	Mar. 31, 2022 USD ($)
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 470		$ 953	$ 1,043
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Net Investment Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount | €		€ 450
Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	786		1,167	531
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	2,320		430	1,106
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 108		$ 9	$ 81

Financial Instruments Cash Flow

Financial Instruments Cash Flow Hedges Included in AOCI (Details) - Designated as Hedging Instrument [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Remaining Maturity	2 years
Beginning Balance	$ 55	$ 47
Additions and revaluations of derivatives designated as cash flow hedges	(41)	63
Clearance of hedge results to earnings	(15)	(14)
Ending Balance	(1)	96
After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months	6
Derivative, Notional Amount	$ 786	531	$ 1,167
Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Remaining Maturity	2 years
Beginning Balance	$ 10	32
Additions and revaluations of derivatives designated as cash flow hedges	(10)	(82)
Clearance of hedge results to earnings	(1)	2
Ending Balance	(1)	(48)
After-tax net gain (loss) to be reclassified from AOCL into earnings over the next twelve months	1
Derivative, Notional Amount	$ 470	$ 1,043	$ 953

Financial Instruments Fair Valu

Financial Instruments Fair Value of Derivatives (Details) - USD ($) $ in Millions		Mar. 31, 2023		Dec. 31, 2022		Mar. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross		$ 43		$ 96		$ 45
Derivative Asset, Counterparty and Cash Collateral Netting	[1]	(35)		40		(28)
Derivative Asset, Net		8		56		17
Derivative Liability, Gross		102		70		197
Derivative Liability, Counterparty and Cash Collateral Netting	[1]	(35)		(40)		(28)
Derivative Liability, Net		67		30		169
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Current Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross				41		16
Derivative Asset, Counterparty and Cash Collateral Netting	[1]			0		0
Derivative Asset, Net				41		16
Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Accrued and Other Current Liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Liability, Gross		21		9		80
Derivative Liability, Counterparty and Cash Collateral Netting		0		0	[1]	0	[1]
Derivative Liability, Net		21		9		80
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Other Current Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross				4		5
Derivative Asset, Counterparty and Cash Collateral Netting				0		0
Derivative Asset, Net				4		5
Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Accrued and Other Current Liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Liability, Gross		10		3
Derivative Liability, Counterparty and Cash Collateral Netting		0	[1]	0
Derivative Liability, Net		10		3
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Current Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross		41		51		21
Derivative Asset, Counterparty and Cash Collateral Netting	[1]	(35)		(40)		(28)
Derivative Asset, Net		6		11		(7)
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Accrued and Other Current Liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Liability, Gross		66		58		114
Derivative Liability, Counterparty and Cash Collateral Netting	[1]	(35)		(40)		(28)
Derivative Liability, Net		31		$ 18		86
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Other Current Assets [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Gross		2				3
Derivative Asset, Counterparty and Cash Collateral Netting		0	[1]			0
Derivative Asset, Net		2				3
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Accrued and Other Current Liabilities [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Liability, Gross		5				3
Derivative Liability, Counterparty and Cash Collateral Netting		0				0
Derivative Liability, Net		$ 5				$ 3
[1]Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Financial Instruments Effect of

Financial Instruments Effect of Derivative Instruments (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) on Derivative Instruments, Net, Pretax	[1]	$ 2	$ (96)
Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax	[2]	(73)	(9)
Amount of gain (loss) recognized in Income - Pre-tax	[1]	21	15
Designated as Hedging Instrument [Member] | Net Investment Hedging [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), Reclassification, before Tax	[2]	0	7
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Foreign Currency Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	[2]	(15)	(102)
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Foreign Currency Contract [Member] | Cost of Goods Sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in Income - Pre-tax	[1],[3]	2	(3)
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	[2]	(58)	86
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Commodity Contract [Member] | Cost of Goods Sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in Income - Pre-tax	[1],[3]	19	18
Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax	[1]	(19)	(111)
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Cost of Goods Sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax	[1],[3]	(12)	(36)
Not Designated as Hedging Instrument [Member] | Foreign Currency Contract [Member] | Other Income - net
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax	[1],[4]	(3)	(53)
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Cost of Goods Sold
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax	[1],[3]	(1)	(22)
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member] | Other Income - net
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income - pre-tax		$ (3)	$ 0
[1]For cash flow hedges, this represents the portion of the gain (loss) reclassified from accumulated OCI into income during the period.[2]OCI is defined as other comprehensive income (loss).[3]Recorded in cost of goods sold in the interim Consolidated Statements of Operations.[4]ecognized in other income (expense). Note that net loss from foreign currency contracts was partially offset by the related gain on the foreign currency-denominated monetary assets and liabilities of the company's operations. See Note 6 - Supplementary Information, to the interim Consolidated Financial Statements, for additional information.

Financial Instruments Contractu

Financial Instruments Contractual Maturities (Details) $ in Millions	Mar. 31, 2023 USD ($)
Debt Securities, Available-for-sale [Line Items]
Amortized Cost, Within One Year	$ 83

Financial Instruments (Details)

Financial Instruments (Details) $ in Millions	Mar. 31, 2023 USD ($)
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost, Within One Year	$ 83

Financial Instruments (Detail_2

Financial Instruments (Details) $ in Millions	Mar. 31, 2023 USD ($)
Schedule of Held-to-maturity Securities [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five	$ 27

Financial Instruments (Detail_3

Financial Instruments (Details) $ in Millions	Mar. 31, 2023 USD ($)
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost, Within One Year	$ 83

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	Mar. 31, 2023		Dec. 31, 2022	Mar. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset	$ 43		$ 96	$ 45
Derivative Liability	102		70	197
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities				0
Equity Securities,				29
Assets at Fair Value				29
Liabilities at Fair Value				0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | Foreign Currency Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset				0
Derivative Liability				0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset				0
Derivative Liability				0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	85		124	290
Equity Securities,	0		0	0
Assets at Fair Value	128		220	335
Liabilities at Fair Value	102		70	197
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Foreign Currency Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset	41		92	37
Derivative Liability	15	[1]	3	3
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Commodity Contract [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Derivative Asset	2	[1]	4	8
Derivative Liability	$ 87	[1]	$ 67	$ 194
[1]See Note 16 - Financial Instruments for the classification of derivatives in the interim Consolidated Balance Sheets.

Segment Reporting Segment Infor

Segment Reporting Segment Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023		Mar. 31, 2022		Dec. 31, 2022
Segment Reporting Information [Line Items]
Net Sales	$ 4,884		$ 4,601
Segment operating EBITDA	1,255		1,060
Segment Assets	41,550		38,290		$ 37,049
EID [Member]
Segment Reporting Information [Line Items]
Net Sales	4,884		4,601
Segment operating EBITDA	1,255		1,060
Seed [Member]
Segment Reporting Information [Line Items]
Net Sales	2,695		2,524
Segment operating EBITDA	652		569
Segment Assets	23,966	[1]	24,146	[1]	22,952
Crop Protection [Member]
Segment Reporting Information [Line Items]
Net Sales	2,189		2,077
Segment operating EBITDA	603		491
Segment Assets	$ 17,584	[1]	$ 14,144	[1]	$ 14,097
[1]Segment assets at December 31, 2022 were $22,952 million and $14,097 million for Seed and Crop Protection, respectively.

Segment Reporting Segment Recon

Segment Reporting Segment Reconciliation (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Income (loss) from continuing operations after income taxes		$ 607	$ 577
Provision for (benefit from) income taxes on continuing operations		169	121
Income from continuing operations before income taxes		776	698
Interest income		40	15
Interest Expense		31	9
Exchange (gains) losses - net	[1]	(36)	(47)
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges			27
Segment operating EBITDA		1,255	1,060
EID [Member]
Segment Reporting Information [Line Items]
Provision for (benefit from) income taxes on continuing operations		166	119
Income from continuing operations before income taxes		763	689
Segment operating EBITDA		1,255	1,060
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Depreciation and Amortization		287	307
Interest income		(40)	(15)
Exchange (gains) losses - net		36	47
Non-operating benefits - net		43	(65)
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges		(15)	(36)
Significant Items		(83)	(22)
Corporate Expenses		24	21
Segment Reconciling Items [Member] | EID [Member]
Segment Reporting Information [Line Items]
Depreciation and Amortization		287	307
Interest income		(40)	(15)
Interest Expense		44	18
Exchange (gains) losses - net		36	47
Non-operating benefits - net		43	(65)
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges		(15)	(36)
Significant Items		83	22
Corporate Expenses		$ 24	$ 21
[1]Includes net pre-tax exchange gains (losses) of $(21) million and $(15) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2023 and 2022, respectively.

Segment Reporting Segment Asset

Segment Reporting Segment Asset Reconciliation (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Segment Reporting [Abstract]
Segment Assets	$ 41,550	$ 37,049	$ 38,290
Corporate Assets	3,950	5,569	4,343
Total Assets	$ 45,500	$ 42,618	$ 42,633

Segment Reporting Significant I

Segment Reporting Significant Items (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net		$ 33	$ 5
2022 Restructuring Actions
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net	[1],[2]	11
Seed [Member] | 2022 Restructuring Actions
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net		6
Crop Protection [Member] | 2022 Restructuring Actions
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net		1
Corporate Segment | 2022 Restructuring Actions
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net		4
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net	[3]	(33)	(5)
Estimated Settlement Expense	[4]	(49)	(17)
Gain(loss) on sale of assets and equity investments		3
Acquisition-related costs	[5]	(19)
Significant Items		(83)	(22)
Segment Reconciling Items [Member] | 2022 Restructuring Actions- Russia Exit
Segment Reporting Information [Line Items]
Russia Seed Sale, pre-tax benefit	[6],[7]	19
Segment Reconciling Items [Member] | 2022 Restructuring Actions
Segment Reporting Information [Line Items]
Inventory Write-down	[7]	(4)
Segment Reconciling Items [Member] | Seed [Member]
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net	[3]	(21)	(5)
Significant Items		(6)	(5)
Segment Reconciling Items [Member] | Seed [Member] | 2022 Restructuring Actions- Russia Exit
Segment Reporting Information [Line Items]
Russia Seed Sale, pre-tax benefit	[6],[7]	19
Segment Reconciling Items [Member] | Seed [Member] | 2022 Restructuring Actions
Segment Reporting Information [Line Items]
Inventory Write-down	[7]	(4)
Segment Reconciling Items [Member] | Crop Protection [Member]
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net	[3]	(6)	2
Estimated Settlement Expense	[4]	(49)	(17)
Gain(loss) on sale of assets and equity investments		3
Acquisition-related costs	[5]	(19)
Significant Items		(71)	(15)
Segment Reconciling Items [Member] | Corporate Segment
Segment Reporting Information [Line Items]
Restructuring and Asset related charges, net	[3]	(6)	(2)
Significant Items		$ (6)	$ (2)
[1]This amount excludes other pre-tax charges recorded during the three months ended March 31, 2023 impacting the Seed segment included in cost of goods sold and other income (expense) - net, in the company's interim Consolidated Statement of Operations, relating to inventory write-offs and the loss on the sale of the company's interest in an equity investment.[2]This amount excludes other pre-tax charges recorded during the three months ended March 31, 2023 included in cost of goods sold and other income (expense) - net, in the company's interim Consolidated Statement of Operations, relating to inventory write-offs and the loss on the sale of the company's interest in an equity investment.[3]Includes Board approved restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements for additional information.[4]Consists of estimated Lorsban® related charges.[5]Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up. See Note 3 - Business Combinations, to the interim Consolidated Financial Statements, for additional information[6]Includes a benefit of $19 million relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the company was contractually required to purchase. It consists of $41 million of net sales and $22 million of cost of goods sold.[7]Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions.

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ in Millions	8 Months Ended
	Dec. 29, 2023	May 02, 2023	Mar. 31, 2023
Subsequent Event [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			$ 6,000
Subsequent Event | 2023 repurchase facility
Subsequent Event [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 500
Percentage of outstanding amounts borrowed utilized as collateral		105%
Subsequent Event | 2023 repurchase facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Subsequent Event [Line Items]
Adjusted Term SOFR	0.10%

EID - Basis of Presentation Nar

EID - Basis of Presentation Narrative (Details) - $ / shares	3 Months Ended
	Mar. 31, 2023	Apr. 27, 2023	Dec. 31, 2022	Mar. 31, 2022	Jun. 26, 2019
EID [Member]
Common Stock, Shares, Outstanding	200		200	200
Common Stock, Par Value	$ 0.30	$ 0.30	$ 0.30	$ 0.30
Common Stock, Shares, Outstanding	710,678,000		713,419,000	725,320,000
Common Stock, Par Value	$ 0.01	$ 0.01	$ 0.01	$ 0.01
Corteva [Member] | EID [Member]
Ownership interest in an entity	100%
Corteva [Member]
Common Stock, Par Value	$ 0.01				$ 0.01

EID - Related Party Transacti_2

EID - Related Party Transactions (Details) - EID [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Related Party Transaction [Line Items]
Long-term debt - related parties	$ 429	$ 1,825	$ 789
Corteva [Member]
Related Party Transaction [Line Items]
Debt, Weighted Average Interest Rate	6.52%	1.67%	6.52%
Interest Expense	$ 13	$ 9
Accrued and Other Current Liabilities [Member] | Corteva [Member]
Related Party Transaction [Line Items]
CTVA Related Party Liability	32	32	$ 31
Other noncurrent obligations | Corteva [Member]
Related Party Transaction [Line Items]
CTVA Related Party Liability	$ 115	$ 116	$ 115

EID Segment FN Segment reconcil

EID Segment FN Segment reconciliation (Details) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Provision for (benefit from) income taxes on continuing operations		$ 169	$ 121
Income from continuing operations before income taxes		776	698
Interest income		40	15
Interest Expense		31	9
Exchange (gains) losses - net	[1]	(36)	(47)
Segment operating EBITDA		1,255	1,060
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges			27
EID [Member]
Segment Reporting Information [Line Items]
Income from Continuing Operations After Taxes		597	570
Provision for (benefit from) income taxes on continuing operations		166	119
Income from continuing operations before income taxes		763	689
Segment operating EBITDA		1,255	1,060
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Depreciation and Amortization		287	307
Interest income		(40)	(15)
Exchange (gains) losses - net		36	47
Non-operating benefits - net		43	(65)
Significant Items		(83)	(22)
Corporate Expenses		24	21
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges		(15)	(36)
Segment Reconciling Items [Member] | EID [Member]
Segment Reporting Information [Line Items]
Depreciation and Amortization		287	307
Interest income		(40)	(15)
Interest Expense		44	18
Exchange (gains) losses - net		36	47
Non-operating benefits - net		43	(65)
Significant Items		83	22
Corporate Expenses		24	21
Mark-to-market gain (loss) on certain foreign currency contracts not designated as hedges		(15)	(36)
Crop Protection [Member]
Segment Reporting Information [Line Items]
Segment operating EBITDA		603	491
Crop Protection [Member] | Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Significant Items		$ (71)	$ (15)
[1]Includes net pre-tax exchange gains (losses) of $(21) million and $(15) million associated with the devaluation of the Argentine peso for the three months ended March 31, 2023 and 2022, respectively.

EID Segment FN Segment Asset Re

EID Segment FN Segment Asset Reconciliation (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
EID [Member]
Segment Reporting Information [Line Items]
Total Assets	$ 45,500	$ 42,618	$ 42,633
Segment Assets	41,550	37,049	38,290
Corporate Assets	3,950	5,569	4,343
Total Assets	$ 45,500	$ 42,618	$ 42,633